fluoxetine has been researched along with citalopram in 453 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (4.86) | 18.7374 |
| 1990's | 61 (13.47) | 18.2507 |
| 2000's | 167 (36.87) | 29.6817 |
| 2010's | 162 (35.76) | 24.3611 |
| 2020's | 41 (9.05) | 2.80 |
| Authors | Studies |
|---|---|
| Cyriac, G; Javitch, JA; Katz, JL; Kopajtic, T; Newman, AH; Zhang, P; Zhao, Y | 1 |
| Costanzo, MJ; Maryanoff, BE; McComsey, DF; Nortey, SO; Shank, RP; Vaught, JL | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Chi, DY; Choe, YS; Chu, S; Jeong, KJ; Jin, C; Lee, BC; Lee, BS | 1 |
| Dormann, SM; Haefeli, WE; Kerpen, CJ; Ketabi-Kiyanvash, N; Martin-Facklam, M; Weiss, J | 1 |
| Caccia, S; Casini, A; Scozzafava, A; Supuran, CT | 1 |
| Keserü, GM | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H | 1 |
| Eid, NM; George, RF; Hanna, MM; Safwat, HM | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Andersen, J; Bang-Andersen, B; Eildal, JN; Jørgensen, AM; Jørgensen, M; Kristensen, AS; Strømgaard, K | 1 |
| Jia, L; Sun, H | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Sen, S; Sinha, N | 1 |
| Bagale, SM; Brown, AS; Gonzalez, MM; Hentall, ID; Kumar, NS; Micotto, TL; Vitores, A; Wilson, JN | 1 |
| Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Peters, JU | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Qin, W; Tian, S; Wold, EA; Xu, Q; Ye, N; Zhen, XC; Zhou, J | 1 |
| Bojarski, AJ; Bugno, R; Duszyńska, B; Hogendorf, A; Hogendorf, AS; Kurczab, R; Lenda, T; Pietruś, W; Satała, G; Staroń, J; Wantuch, A; Warszycki, D | 1 |
| Anestis, DK; Gruetter, CA; Lemke, SM; Szarek, JL; Valentovic, MA | 1 |
| Karsch, V; Starke, K; Szabo, B | 1 |
| Crewe, HK; Haddock, RE; Lennard, MS; Tucker, GT; Woods, FR | 1 |
| Maj, J; Rogóz, Z; Skuza, G; Sowińska, H | 3 |
| Bhattacharya, SK; Datla, KP; Mitra, SK | 1 |
| Bäckström, IT; Marcusson, JO | 1 |
| Ciesielski, L; Gobaille, S; Isel, F; Mandel, P; Molina, V | 1 |
| Esnaud, H; Graham, D; Habert, E; Langer, SZ | 1 |
| Schmidt, CJ; Taylor, VL | 1 |
| Fuller, RW | 1 |
| Asberg, M; Eriksson, B; Mårtensson, B; Träskman-Bendz, L; Wägner, A | 1 |
| Rényi, L | 1 |
| Mendels, J | 1 |
| Bergström, M; Eriksson, K; Marcusson, JO; Ross, SB | 1 |
| Ostrow, D | 1 |
| Durcan, MJ; Eckardt, MJ; Linnoila, M; Lister, RG | 2 |
| Collard, KJ; Evans, SM | 1 |
| Adler-Graschinsky, E; Butta, NV; Elgoyhen, AB | 1 |
| Fagervall, I; Ross, SB | 1 |
| Hwang, SA; Wilcox, GL | 1 |
| Deyo, SN; Fessler, RG; Meltzer, HY; Miller, RJ | 1 |
| Buckholtz, NS; Sparks, DL | 1 |
| Jobe, PC; Ray, TB | 1 |
| Holmgren, B; Urbá-Holmgren, R | 1 |
| Barkla, DH; Tutton, PJ | 1 |
| Hatzinger, M; Hemmeter, U; Holsboer-Trachsler, E; Müller, MJ; Seifritz, E | 1 |
| Bastide, P; Coudert, P; Rubat, C; Tronche, P | 1 |
| Baumann, P; Rochat, B | 1 |
| Hyttel, J; Sánchez, C | 1 |
| Gackenheimer, SL; Gehlert, DR; Schober, DA | 1 |
| Dewey, SL; Fowler, JS; Gatley, SJ; King, P; Logan, J; MacGregor, RR; Pappas, N; Schlyer, DJ; Volkow, ND; wang, GJ | 1 |
| Hietala, J; Kuoppamäki, M; Laakso, A; Pälvimäki, EP; Syvälahti, E | 2 |
| Chen, NH; Reith, ME | 1 |
| Brøsen, K | 2 |
| Klimek, V; Mackowiak, M; Zak-Knapik, J | 1 |
| Meert, TF | 1 |
| Esposito, E; Prisco, S | 1 |
| Chiba, K; Ishizaki, T; Kobayashi, K; Kuroiwa, Y; Tani, M; Yamamoto, T | 1 |
| Bouchard, JM; Bougerol, T; Charbonnier, JF; Chevalier, JF; Clerc, G; Cyran, C; Høpfner Petersen, HE; Lemming, O; Patris, M; Van Amerongen, P | 1 |
| Artigas, F; Bel, N | 1 |
| Berk, M; Koopowitz, LF; Szabo, CP | 1 |
| Hietala, J; Kuoppamäki, M; Laakso, A; Majasuo, H; Pälvimäki, EP; Roth, BL; Syvälahti, E | 1 |
| Brøsen, K; Gram, LF; Jeppesen, U; Loft, S; Poulsen, HE; Vistisen, K | 1 |
| Catalano, M; Lucca, A; Lucini, V; Smeraldi, E | 1 |
| Harnett-Sheehan, K; Sheehan, DV | 1 |
| Baumann, P; Eap, CB | 1 |
| Hughes, ZA; Stanford, SC | 2 |
| Meier, E; Sánchez, C | 1 |
| Earley, B; Faherty, CJ; Leonard, BE | 1 |
| Mellerup, ET; Plenge, P | 1 |
| Bourin, M; Redrobe, JP | 2 |
| Fujii, M; Hatanaka, K; Hattori, H; Koshiya, K; Nakato, K; Sonoda, R; Takeuchi, H; Yamaguchi, T; Yatsugi, S | 1 |
| Crespi, D; Foddi, MC; Fracasso, C; Gobbi, M; Mancini, L; Mennini, T; Parotti, L | 1 |
| Bunin, MA; Mailman, RB; Prioleau, C; Wightman, RM | 1 |
| Legutko, B; Nowak, G; Popik, P; Skolnick, P | 1 |
| Leander, JD; Wolff, MC | 1 |
| Allikmets, L; Matto, V; Skrebuhhova, T | 1 |
| Belpaire, FM; Brøsen, K; Rasmussen, BB; Temmerman, A; Wijnant, P | 1 |
| Marona-Lewicka, D; Nichols, DE | 1 |
| Dailey, JW; Jobe, PC; Milbrandt, JC; Reith, ME; Steidley, KR | 1 |
| Barbey, JT; Roose, SP | 1 |
| Stahl, SM | 1 |
| Harkin, A; Kelly, JP; Leonard, BE; Redmond, AM | 1 |
| Furst, S; Kecskemeti, V; Nanasi, PP; Pacher, P; Ungvari, Z | 1 |
| Meyers, BS | 1 |
| De Vry, J; Maurel, S; Schreiber, R | 1 |
| Koran, LM; Pallanti, S | 1 |
| Kristensen, AS; Mortensen, OV; Rudnick, G; Wiborg, O | 1 |
| Thompson, C | 1 |
| Nutt, DJ | 1 |
| Garavaglia, C; Invernizzi, R; Pozzi, L; Samanin, R | 1 |
| Carleborg, L; Hägg, S; Ohman, R; Spigset, O | 1 |
| Bugge, A; Kristoffersen, L; Lundanes, E; Slørdal, L | 1 |
| Blundell, P; Gonzalez, MD; Liang, AY; Madras, BK; Meltzer, PC; Niznik, HB; Pristupa, ZB | 1 |
| Härtter, S; Hiemke, C | 1 |
| Hatanaka, K; Yamaguchi, T; Yatsugi, S | 2 |
| Elie, R; Habimana, A; Hébert, C; Reader, TA | 1 |
| De Deurwaerdère, P; Lucas, G; Porras, G; Spampinato, U | 1 |
| Buzinkaiová, T; Polonský, J | 1 |
| Kubera, M; Maes, M; Mathison, R; Simbirtsev, A | 1 |
| Terao, T | 1 |
| Gorman, JM; Nierenberg, AA; Stahl, SM | 1 |
| Hanus, H; Hosák, L; Straka, L; Tůma, I | 1 |
| Soini, M | 1 |
| Kremer, C; Quitkin, FM; Taylor, BP | 1 |
| Appelberg, BG; Koskinen, TE; Mehtonen, OP; Muhonen, TT; Naukkarinen, HH; Syvälahti, EK | 1 |
| Bergsholm, YK; Bøhler, E; Nordeng, H; Spigset, O | 1 |
| Friedmann, T; Furst, S; Kecskeméti, V; Pacher, P; Ungvari, Z | 1 |
| Knight, DL; Nemeroff, CB; Owens, MJ | 1 |
| Knoke, DM; Naranjo, CA | 1 |
| Feighner, JP; Lydiard, RB; Thase, ME | 1 |
| Greibrokk, T; Kristoffersen, L; Lundanes, E; Molander, P; Thomassen, A | 1 |
| Yan, QS | 1 |
| Hancox, JC; Hofmann, G; Pabbathi, VK; Paul, AA; Witchel, HJ | 1 |
| Chu, S; Jin, C; Lee, BS; Se Lee, B; Song, YS; Yoon Chi, D | 1 |
| Barnes, NM; Blakely, RD; Bowery, NG; Chamba, A; Gordon, J; Grafton, G; Gregory, CD; Serafeim, A | 1 |
| Brown, EB; Gonzales, JS; Miner, CM; Munir, R | 1 |
| Cullen, N; Lexell, J; Zafonte, RD | 1 |
| Doat, MM; Eckler, JR; Rabin, RA; Winter, JC | 2 |
| Majlessi, N; Naghdi, N | 1 |
| Baumann, P; Eap, CB; Zullino, DF | 1 |
| Ekblad, U; Heikkine, T; Laine, K | 1 |
| Takeuchi, H; Yamaguchi, T; Yatsugi, S | 1 |
| Fei, Y; Ganapathy, V; Gillespie, CF; Hobby, HM; Leibach, FH; Rausch, JL; Stoming, T | 1 |
| Ginovart, N; Houle, S; Hussey, D; Meyer, JH; Wilson, AA | 1 |
| Bergman, J; Brust, P; Eskola, O; Hinz, R; Johannsen, B; Kretzschmar, M; Kuwabara, H; Pawelke, B; Solin, O; Steinbach, J; Zessin, J | 1 |
| Conca, A; Hubmann, MR; König, P; Moll, W; Waschgler, R | 1 |
| Barnes, NM; Bunce, CM; Chamba, A; Drayson, MT; Gordon, J; Grafton, G; Gregory, CD; Holder, MJ; Luong, QT; Serafeim, A | 1 |
| Anderson, TA; Dobscha, SK; Hauser, P; Hoffman, WF; Snodgrass, LS; Turner, EH; Winterbottom, LM | 1 |
| Akarachkova, ES; Dlusskaia, IG; Striuk, RI; Tabeeva, GR; Veĭn, AM; Volkova, ZI | 1 |
| Levenson, JL | 1 |
| Altshuler, LL; Haynes, D; Hendrick, V; Hwang, S; Lee, E; Stowe, ZN | 1 |
| Czarnecka, E; Pietrzak, B | 1 |
| Calabrese, JR; Londborg, PD; Shelton, MD; Thase, ME | 1 |
| Birmes, P; Coppin, D; Lauque, D; Schmitt, L | 1 |
| Adnot, S; Eddahibi, S; Hamon, M; Marcos, E; Nosjean, A; Pham, MH; Raffestin, B | 1 |
| Bagheri, H; Montastruc, JL; Schmitt, L | 1 |
| Corda, MG; Driscoll, P; Giorgi, O; Hansson, S; Lecca, D; Piras, G | 1 |
| Horschitz, S; Hummerich, R; Schloss, P | 1 |
| Hall, J; Herrmann, N; Naranjo, CA; Sproule, BA | 1 |
| Jain, NK; Kulkarni, SK; Patil, CS; Singh, A; Singh, VP | 1 |
| Broocks, A; Hohagen, F; Kordon, A | 1 |
| Akin, A; Chaturvedi, AK | 1 |
| Baker, GB; Fletcher, PJ; Salsali, M; Sinyard, J | 1 |
| Bagdy, G; Gerber, K; Graf, M; Halasz, P; Jakus, R; Juhasz, G; Levay, G | 1 |
| Dakhale, GN; Khanzode, SD; Khanzode, SS; Palasodkar, R; Saoji, A | 1 |
| Kecskeméti, V; Pacher, P | 1 |
| Bateman, DN; Chick, J; Good, AM; Kelly, CA; Masterton, G | 1 |
| Carella, A; Cheok, A; Ginovart, N; Houle, S; Hussey, D; Meyer, JH; Potter, WZ; Sagrati, S; Spencer, EP; Wilson, AA | 1 |
| Cryan, JF; Dalvi, A; Friedland, JC; Hirsch, BR; Jin, SH; Lucki, I; O'Leary, OF; Ouyang, M; Page, ME; Thomas, SA | 1 |
| Conca, A; König, P; Moll, W; Prapotnik, M; Waschgler, R | 1 |
| Boot, JR; Broadmore, RJ; Cooper, J; Eyre, TA; Mitchell, SN; Pullar, IA; Sanger, GJ; Wedley, S | 1 |
| Brown, EB; Joliat, MJ; Miner, CM | 1 |
| Vasil'chikova, NV; Vorob'eva, OV | 1 |
| Eichner, SF; Jones, JR; Moore, ML | 1 |
| Armbrust, KL; Black, MC; Henry, TB; Kwon, JW | 1 |
| Albert, U; Bogetto, F; Maina, G; Salvi, V | 1 |
| Calviño, MA; Iscla, IR; Szczupak, L | 1 |
| Fujita, M; Ghose, S; Halldin, C; Innis, R; Morrison, P; Mozley, PD; Murphy, DL; Schou, M; Uhl, G | 1 |
| Hietala, J; Majasuo, H; Pälvimäki, EP; Syvälahti, E | 1 |
| Chen, JY; Chen, YA; Tao, PL; Wu, CC; Yeh, GC | 1 |
| Argyropoulos, S; Hale, AS; Willner, P | 1 |
| Huande, L; Juan, H; Zhiling, Z | 1 |
| Hill, D; Mines, D; Novelli, L; Yu, H | 1 |
| Sharma, S; Tandon, R; Trivedi, JK | 1 |
| Egberts, AC; Heerdink, ER; Hugtenburg, JG; van Geffen, EC; van Hulten, RP | 1 |
| Egberts, TC | 1 |
| Cyranowski, JM; Fagiolini, A; Frank, E; Kupfer, DJ; Scott, J; Shear, MK; Swartz, H | 1 |
| Cela, R; Garcia-Jares, C; Lamas, JP; Llompart, M; Salgado-Petinal, C | 1 |
| Lin, F; Sehgal, A; Yuan, Q; Zheng, X | 1 |
| Akaike, A; Katsuki, H | 1 |
| Grundt, P; Katz, JL; Kopajtic, TA; Newman, AH | 1 |
| Hutson, PH; Ivarsson, M; Paterson, LM | 1 |
| de Swart, H; Friis Andersen, H; Kasper, S | 1 |
| Adkins, EM; Blakely, RD; Field, JR; Henry, LK; Newman, AH; Parnas, ML; Vaughan, RA; Zou, MF | 1 |
| Lambert, WE; Maudens, KE; Van Peteghem, CH; Wille, SM | 1 |
| Carrasco, JL; Sandner, C | 1 |
| Fukushima, S; Hall, FS; Kobayashi, H; Numachi, Y; Shen, HW; Sora, I; Uhl, GR; Yamashita, M | 1 |
| Pick, CG; Schreiber, S | 1 |
| Benturquia, N; Haddjeri, N; Mansari, ME; Mnie-Filali, O; Sánchez, C; Wiborg, O | 1 |
| Albertazzi, P | 1 |
| Berger, U; Jensen, E; Kallenborn, R; Samuelsen, PJ; Vasskog, T | 1 |
| Csoka, AB; Shipko, S | 1 |
| Hogg, S; Jessa, M; Michan, L | 1 |
| Albano, C; Cupello, A; Favale, E; Mainardi, P; Scarrone, S | 1 |
| Berzas Nevado, JJ; Guiberteau Cabanillas, C; Rodríguez Robledo, V; Villaseñor Llerena, MJ | 1 |
| Cano, E; Fraiz, N; Orallo, F; Yáñez, M | 1 |
| Juvonen, R; Korhonen, LE; Pelkonen, O; Raunio, H; Tolonen, A; Turpeinen, M; Uusitalo, J | 1 |
| Greenhill, LL; Moreno, C; Roche, AM | 1 |
| Koht, J; Refsum, H; Solberg, DK | 1 |
| Bechtholt, AJ; Crowley, JJ; Lucki, I; O'Leary, OF; Valentino, RJ | 1 |
| Bailly, D | 1 |
| Haro, JM; Peñarrubia, MT; Pinto-Meza, A; Serrano-Blanco, A; Suárez, D | 1 |
| Ashby, CR; Blackburn, TP; Ramachandran, PV; Sekine, Y; Suzuki, K | 1 |
| Cai, ZJ; Gu, X; Jiang, F; Li, M; Ma, C; Mao, PX; Mitchell, PB; Qian, M; Shu, L; Tang, YL | 1 |
| Andrews, E; Mines, D; Roskell, N; Rubino, A; Tennis, P; Weich, S | 1 |
| da Rocha, FF; Malheiros, MM | 1 |
| Bechtholt, AJ; Crowley, JJ; Hill, TE; Lucki, I; O'Leary, OF; Page, ME | 1 |
| Colucci-D'Amato, L; Di Lieto, A; di Porzio, U; Leo, D; Volpicelli, F | 1 |
| Alexander, IM; Moore, A | 1 |
| Deutsch, HM; Kim, DI; Schweri, MM; Ye, X | 1 |
| Detke, MJ; Faries, DE; Mallinckrodt, CH; Meyers, AL; Prakash, A | 1 |
| Burghardt, NS; Bush, DE; LeDoux, JE; McEwen, BS | 1 |
| Alacqua, M; Arcoraci, V; Calarese, T; Di Vita, G; Gagliano, C; Germanò, E; Magazù, A; Spina, E; Trifirò, G | 1 |
| Hetrick, S; McKenzie, J; Merry, S; Proctor, M; Sindahl, P | 1 |
| Kraft, K | 1 |
| Abdel-Magid, N; Azmitia, EC; El-Nour, H; Lonne-Rahm, SB; Lundeberg, L; Nordlind, K | 1 |
| Csete, K; Papp, JG; Sas, K; Sztriha, L; Vécseil, L; Vezekényi, Z | 1 |
| Altunayoglu, V; Boz, C; Gazioglu, S; Hocaoglu, C | 1 |
| Bekele, NB; Shih, YC; Xu, Y | 1 |
| Benattia, I; Demitrack, M; Entsuah, R; Nemeroff, CB; Sloan, DM; Thase, ME | 1 |
| Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A | 1 |
| Hata, Y; Hirano, S; Kamei, J; Miyata, S; Ohsawa, M; Shimoi, T; Yamada, N; Yoshikawa, N | 1 |
| Detke, MJ; Fava, M; Houston, JP; Mallinckrodt, CH; Prakash, A; Swindle, R | 1 |
| Alcalde, AI; Aramayona, JJ; Iceta, R; Mesonero, JE | 1 |
| Bylund, DB; Happe, HK; Petty, F; Reed, AL | 1 |
| Barrio, RJ; Goicolea, MA; Gómez-Caballero, A; Millán, S; Sallés, J; Sampedro, MC; Sánchez, A; Unceta, N | 1 |
| Abebe, K; Asarnow, JR; Birmaher, B; Brent, D; Clarke, G; DeBar, L; Emslie, G; Hughes, C; Iyengar, S; Keller, M; Kennard, B; Leonard, H; McCracken, J; Melhem, N; Onorato, M; Porta, G; Ritz, L; Ryan, N; Spirito, A; Strober, M; Suddath, R; Vitiello, B; Wagner, KD; Zelazny, J | 1 |
| Gehlert, DR; Hemrick-Luecke, SK; Shaw, J; Thompson, LK | 1 |
| Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH | 1 |
| Adrien, J; Alexandre, C; Léna, C; Popa, D | 1 |
| Balestrieri, A; Bettica, P; Carani, C; Granata, AR; Madeo, B; Milleri, S; Rochira, V | 1 |
| Aperi, J; Borenstein, J; Jones, JB; Karne, A; Shah, NR; Shemtov, R | 1 |
| Craighead, M; Gartside, SE; Grant, EJ; Ingram, CD; Johnson, DA | 1 |
| Hummel, R; Jacobsen, JP; Mirza, N; Nielsen, EØ; Redrobe, JP; Weikop, P | 1 |
| Akar, FY; Erden, BF; Komsuoğlu, FI; Mutlu, O; Tanyeri, P; Ulak, G | 1 |
| Chen, TJ; Hong, CJ; Liou, YJ; Tsai, SJ; Yu, YW | 1 |
| Anders, M; Fisar, Z; Kalisová, L; Paclt, I; Vevera, J | 1 |
| Bouchez, G; Brocco, M; Dekeyne, A; Di Cara, B; Gannon, RL; Gobert, A; Lejeune, F; Millan, MJ | 1 |
| Balch, AH; Berman, RM; Boulton, DW; Mallikaarjun, S; Patel, CG; Reeves, RA; Royzman, K | 1 |
| Bunchapattanasakda, C; Kongsakon, R | 1 |
| Ikonomidis, I; Kremastinos, DT; Lekakis, J; Moutsatsou, P; Nikolaou, M; Papoutsi, Z; Parissis, J | 1 |
| Garriock, HA; Hamilton, SP; Jenkins, GD; Kraft, JB; McGrath, PJ; Peters, EJ; Reinalda, MS; Shyn, SI; Slager, SL | 1 |
| Blicharska, E; Brański, P; Cichy, A; Dybała, M; Nowak, G; Pilc, A; Piotrowska, A; Poleszak, E; Pomierny-Chamioło, L; Siwek, A; Szewczyk, B; Wlaź, P; Wróbel, A | 1 |
| Alaghband-Rad, J; Hakimshooshtary, M | 1 |
| Asarnow, J; Birmaher, B; Brent, DA; Clarke, GN; Debar, LL; Emslie, GJ; Iyengar, S; Keller, MB; Kennard, B; Leonard, H; Mayes, TL; McCracken, JT; Onorato, M; Porta, G; Ritz, L; Ryan, ND; Spirito, A; Strober, M; Suddath, R; Vitiello, B; Zelazny, J | 1 |
| Davidson, S; Gil-Ad, I; Harell, D; Maayan, R; Prokonov, D; Taler, M; Weizman, A | 1 |
| Chen, TJ; Hong, CJ; Hou, SJ; Liou, YJ; Tsai, SJ; Yen, FC; Yu, YW | 1 |
| Aso, E; Hamon, M; Lanfumey, L; Ledent, C; Maldonado, R; Mengod, G; Renoir, T; Valverde, O | 1 |
| Alvarez, E; de Diego-Adeliño, J; Pérez, V; Pérez-Egea, R; Portella, MJ; Puigdemont, D | 1 |
| Calişkan, M; Gören, MZ; Kaplan, OK; Küçükibrahimoğlu, E; Saygin, MZ; Unsal, C | 1 |
| Croghan, TW; Daniel, G; Erder, MH; Esposito, D; Stoto, MA; Wahl, P | 1 |
| Carrilho, E; Catai, AP; Lanças, FM; Queiroz, ME | 1 |
| Bertoletti, E; Chilovi, BV; Conti, M; Padovani, A; Rozzini, L; Trabucchi, M; Zanetti, M | 1 |
| Huhtala, H; Illi, A; Kampman, O; Lehtimäki, T; Leinonen, E; Mononen, N; Poutanen, O; Setälä-Soikkeli, E; Viikki, M | 1 |
| Anderssen, T; Bergersen, O; Eggen, T; Jensen, E; Vasskog, T | 1 |
| Barrio, RJ; Goicolea, MA; Gómez-Caballero, A; Sánchez, A; Ugarte, A; Unceta, N | 1 |
| Lanza di Scalea, T; Wisner, KL | 1 |
| Chen, ML; Chen, TJ; Hong, CJ; Hou, SJ; Liou, YJ; Tsai, SJ; Yen, FC; Yu, YW | 1 |
| Cavanagh, J; Dewar, D; Patterson, J; Pimlott, S; Wyper, D | 1 |
| Brent, DA | 1 |
| Adori, C; Andó, RD; Bagdy, G; Ferrington, L; Kelly, PA; Kirilly, E; Kovács, GG; Molnár, E | 1 |
| Platt, DM; Rowlett, JK; Rüedi-Bettschen, D; Spealman, RD | 1 |
| Baumer, C; Koren, G; O'Brien, L; Sachs, H; Thieme, D | 1 |
| Böer, U; Cierny, I; Hiemke, C; Knepel, W; Krause, D; Noll, C | 1 |
| Brennan, F; Gregory, B; Medghalchi, M; Sacre, S; Williams, R | 1 |
| Drummer, OH; Gerostamoulos, D; Pilgrim, JL | 1 |
| Baghinia, MR; Dadfar, MR | 1 |
| Alcalde, AI; Iceta, R; Matheus, N; Mendoza, C; Mesonero, JE | 1 |
| Scahill, L; Williamson, E | 1 |
| Charles, D; Fava, M; Papakostas, GI | 1 |
| Dormuth, CR; Lee, JC; Mehta, J; Miller, M; Patrick, AR; Schneeweiss, S; Solomon, DH; Wang, PS | 1 |
| Sas, K | 1 |
| Dormuth, C; Lee, JC; Mehta, J; Miller, M; Patrick, AR; Schneeweiss, S; Solomon, DH; Wang, PS | 1 |
| Nierenberg, AA; Schutte, AJ; Simmons, JH; Thase, ME; van Oers, HJ; Vrijland, P | 1 |
| Agius, M; Gardner, J; Liu, K; Zaman, R | 1 |
| Nikiforuk, A; Popik, P | 1 |
| Heuser, I; Peters, O; Schipke, CG | 1 |
| Mochcovitch, MD; Nardi, AE | 1 |
| Feetam, CL; Nutt, DJ | 1 |
| Celikel, S; Isik, SR; Kalyoncu, AF; Karakaya, G; Ulug, B | 1 |
| Antonioli, L; Blandizzi, C; Colucci, R; Corona, T; Fornai, M; Mantarro, S; Montagnani, S; Pergola, A; Ruggiero, E; Scollo, C; Testi, A; Tuccori, M | 1 |
| Hazell, P; Silove, N; Wheeler, DM; Williams, K | 1 |
| Kaneko, S; Kitagawa, Y; Kitaichi, M; Nagayasu, K; Nakagawa, T; Shirakawa, H; Yatani, Y | 1 |
| Beverley, J; Marinelli, M; Steiner, H; Van Waes, V | 1 |
| Choi, HC; Kang, TC; Kim, DS; Kim, JE; Kim, YI; Song, HK | 1 |
| Lagrou, LM; MacGillivray, L; Mazurek, MF; Reynolds, KB; Rosebush, PI | 1 |
| Halling-Sørensen, B; Ingerslev, F; Styrishave, B | 1 |
| Dobzhenko, MN; Shchepotin, IB; Zotov, AS | 1 |
| Axelson, DA; Birmaher, B; Dahl, RE; Forbes, EE; Jakubcak, JL; Ryan, ND; Silk, JS; Thompson, WK; Whalen, DJ | 1 |
| Asarnow, JR; Birmaher, B; Brent, DA; Clarke, GN; Emslie, GJ; Iyengar, S; Keller, MB; McCracken, JT; Perel, JM; Porta, G; Ryan, ND; Sakolsky, DJ; Strober, MJ; Vitiello, B; Wagner, KD | 1 |
| Fisar, Z; Hroudová, J; Raboch, J | 1 |
| Khazaie, H; Najafi, F; Rahimi, M; Rezaei, M; Tahmasian, M; Tatari, F | 1 |
| Kardeh, E; Mowla, A | 1 |
| Birkett, MA; Kessler, EJ; Meyer, JS; Ritchie, S; Rowlett, JK; Shinday, NM | 1 |
| Bruzek, JL; Jerome, RN; Krishnaswami, S; McPheeters, ML; Sathe, N; Veenstra-Vanderweele, J; Warren, Z | 1 |
| Asmidar, D; Guan, NC; Hod, R; Sidi, H | 1 |
| Chen, EY; Greengard, P; Marshall, JJ; Vanover, KE; Warner-Schmidt, JL | 1 |
| Beste, J; Blackwell, JC; Patel, BN | 1 |
| Getz, A; Syed, NI; Xu, F; Zaidi, W | 1 |
| Dasgupta, K; Labos, C; Nedjar, H; Rahme, E; Turecki, G | 1 |
| Chamielec, M; Gałecki, P; Talarowska, M; Zboralski, K | 1 |
| Bagheri, H; Bondon-Guitton, E; Bui, E; Durrieu, G; Lapeyre-Mestre, M; Montastruc, F; Montastruc, JL; Schmitt, L; Sommet, A | 1 |
| Asmidar, D; Guan, NC; Hod, R; Jaafar, NR; Sidi, H | 1 |
| Chapman, A; Delivuk, M; Gartlehner, G; Gaynes, BN; Kaminski, A; Thaler, K | 1 |
| Monga, V; Padala, KP; Padala, PR; Ramirez, DA; Sullivan, DH | 1 |
| Mandrioli, R; Mercolini, L; Raggi, MA; Saracino, MA | 1 |
| Cortés, JM; Hidalgo, M; Jönsson, JÅ; Larsson, E; Sagristà, E; Salvadó, V | 1 |
| Bishop, C; Buchta, W; Dickinson, SO; Eissa, S; Eskow Jaunarajs, KL; George, JA; Goldenberg, AA; Mohamed, M | 1 |
| Alizadeh, R; Najafi, NM; Poursani, EM | 1 |
| Barbui, C; Cipriani, A; Furukawa, TA; Koesters, M; Nosè, M; Omori, IM; Purgato, M; Trespidi, C | 1 |
| Asmidar, D; Guan, NC; Kanagasundram, S; Midi, M; Naing, L; Sidi, H | 1 |
| Choi, SJ; Hahn, SJ; Hong, YJ; Kim, HJ; Kim, TH; Rhie, DJ; Sung, KW; Yang, JS; Yoon, SH | 1 |
| Cox, GR; Hetrick, SE; McKenzie, JE; Merry, SN; Simmons, MB | 1 |
| Claxton, A; Hackett, ML; Hankey, GJ; Hsieh, CF; Kutlubaev, MA; Lee, R; Mead, GE | 1 |
| Kováru, F; Kovárů, H; Lisá, V | 1 |
| Campos-Torres, A; Haase, J; Malynn, S; Moynagh, P | 1 |
| Corruble, E; Demyttenaere, K; Hale, A; Kasper, S; Picarel-Blanchot, F; Quera-Salva, MA | 1 |
| Gorman, DA; Lam, D; Patten, S; Pringsheim, T | 1 |
| Bornak, E; M-Shirazi, M; Mostafavi, A; Nasrollahzadeh, J; Ranjbar, E; Rashidkhani, B; Sabetkasaei, M; Shams, J | 1 |
| Asarnow, JR; Birmaher, B; Brent, DA; Clarke, GN; Emslie, GJ; He, J; Hilton, RC; Keller, MB; Mansoor, B; Mayes, T; Porta, G; Rengasamy, M; Ryan, N; Shamseddeen, W; Wagner, KD | 1 |
| Abbasi-Asl, M; Alimadadi, A; Berenji, F; Ghaeli, P; Sadeghniiat, K; Shahsavand-Ananloo, E; Tabatabaee, M; Zahiroddin, AR | 1 |
| Bronson, JJ; Davis, CD; Gillman, KW; Lelas, S; Li, YW; Lodge, NJ; Macor, JE; Molski, TF; Newberry, KS; Newton, AE; Parker, MF; Pieschl, RL; Taber, MT; Wallace-Boone, TL | 1 |
| Baker, GB; Churchward, MA; Dhami, KS; Todd, KG | 1 |
| Brański, P; Pałucha-Poniewiera, A; Pilc, A; Stachowicz, K; Sławińska, A; Wierońska, JM | 1 |
| Brignell, A; Hazell, P; Randall, M; Silove, N; Williams, K | 1 |
| Birmaher, B; Brent, D; Clarke, G; Emslie, GJ; He, J; Hilton, R; Mansoor, B; Mayes, TL; Porta, G; Rengasamy, M; Ryan, N; Shamseddeen, W; Spirito, A; Wagner, KD | 1 |
| Cadeddu, R; Carboni, E; Ibba, M; Sadile, A | 1 |
| Cho, HY; Kim, JE; Kim, YH; Lee, BJ; Lee, CH; Lee, JG; Park, SW; Seo, MK; Seol, W | 1 |
| Seyfried, CA; van Amsterdam, C | 1 |
| Chen, HX; Gao, N; Jin, ZL; Li, XR; Li, YF; Tang, Y; Xiong, J; Zhang, JR | 1 |
| Bundeff, AW; Woodis, CB | 1 |
| Handley, AP; Williams, M | 1 |
| Bristow, LJ; Das, ML; Li, YW; Louis, JV; Murugesan, S; Naidu, PS; Prasad, DS; Rudra, A; Siva Subramani, T; Sreedhara, MV; Trivedi, RK; Vijaya Kumar, K; Vikramadithyan, RK; Yadav, R | 1 |
| Becker, T; Koesters, M; Ma, Y; Zhang, Y | 1 |
| Hassanpour Moghadam, M; Mohajeri, SA; Sajadi Tabassi, SA; Talaei, A | 1 |
| IsHak, WW; Karamians, R; Peselow, ED; Pizano, D; Tobia, G | 1 |
| Altieri, SC; Andrews, AM; Hensler, JG; O'Brien, HJ; Redwine, HM; Senturk, D; Yang, H | 1 |
| Hermann, M; Molden, E; Waade, RB | 1 |
| Su, F; Xu, L; Yi, H; Zhang, Z | 1 |
| Dueñas, H; Haro, JM; Hong, J; Moneta, MV; Montgomery, W; Novick, D; Peng, X | 1 |
| Asaoka, N; Kaneko, S; Nagayasu, K; Nakagawa, T; Nishitani, N; Shirakawa, H; Yamashiro, M | 1 |
| Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N | 1 |
| Banzi, R; Cusi, C; Moja, L; Randazzo, C; Sterzi, R; Tedesco, D | 1 |
| Bystrowska, B; Moniczewski, A; Młyniec, K; Nowak, G; Poleszak, E; Rutkowska, A; Siwek, A; Szewczyk, B; Wolak, M | 1 |
| Cantrell, SE; Häuser, W; Nishishinya, MB; Urrútia, G; Walitt, B | 1 |
| Bonan, CD; Lara, DR; Piato, AL; Schaefer, IC; Siebel, AM; Vianna, MR | 1 |
| Halling-Sørensen, B; Hansen, CH; Jacobsen, NW; Nellemann, C; Styrishave, B | 1 |
| Beaulieu, JM; Chahine, M; Poulin, H; Thériault, O | 1 |
| Cao, W; Li, J; Meng, H; Qiu, T | 1 |
| Bannink, M; Binkhorst, L; de Bruijn, P; den Boer, TD; Droogendijk, H; Jager, A; Lam, MH; Mathijssen, RH; Ruit, J; van Alphen, RJ; van Gelder, T | 1 |
| Blakely, RD; McMeekin, AM; Moussa-Tooks, AB; Nackenoff, AG; Veenstra-VanderWeele, J | 1 |
| Bloch, MH; Freemantle, N; Jakubovski, E; Taylor, MJ; Varigonda, AL | 1 |
| Azrael, D; Bushnell, GA; Miller, M; Pate, V; Stürmer, T; Swanson, SA; White, A | 1 |
| Allen, RR; Anderson, HD; Libby, AM; Marangell, LB; Perahia, D; Strombom, I; Valuck, RJ | 1 |
| Becquemont, L; Colle, R; Corruble, E; Dahan, L; David, D; Gardier, AM; Guiard, BP; Guilloux, JP; Nguyen, HT; Petit, AC; Qesseveur, G; Robert, P; Rotenberg, S; Seif, I; Verstuyft, C | 1 |
| Oniszczuk, A; Poleszak, E; Serefko, A; Stasiuk, W; Świąder, K; Szopa, A; Wlaź, P; Wośko, S; Wyska, E | 1 |
| Chen, D; Feng, YQ; Hu, YN; Huang, YQ; Hussain, D; Zhu, GT | 1 |
| Berk, M; Brownstein, DJ; Dodd, S; Fernandes, BS; Salagre, E | 1 |
| Craig, JC; Natale, P; Palmer, SC; Rabindranath, KS; Ruospo, M; Saglimbene, VM; Strippoli, GF | 1 |
| Andreão, RV; Benseñor, IM; Bittencourt, MS; Brunoni, AR; Dantas, EM; Fráguas, R; Kemp, AH; Koenig, J; Lotufo, PA; Mill, JG; Nunes, MA; Ribeiro, AL; Thayer, JF | 1 |
| Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
| Abouchedid, R; Archer, JR; Dargan, PI; Dines, A; Ho, JH; Hudson, S; Wood, DM | 1 |
| DeLucia, V; Kelsberg, G; Safranek, S | 1 |
| Anghelescu, IG; Correll, CU; Gao, K; Normann, C; Reis, C; Schaffer, A; Solmi, M; van der Loos, ML; Veronese, N; Zaninotto, L | 1 |
| Binelli, A; Catani, M; Cavazzini, A; de Oliveira, LF; Della Torre, C; Guzzinati, R; Magni, S; Parolini, M | 1 |
| Brose, SA; Golovko, MY; Henry, LK; Krout, D; Rodriquez, M; Thompson, BJ | 1 |
| Barygin, OI; Belinskaya, DA; Nagaeva, EI; Shestakova, NN; Tikhonov, DB; Vanchakova, NP | 1 |
| Breitfeld, J; Laje, G; Scholl, C; Steffens, M; Stingl, JC | 1 |
| Casavant, MJ; Chounthirath, T; Russell, JL; Spiller, HA | 1 |
| Kamińska, K; Pańczyszyn-Trzewik, P; Rogóż, Z; Sowa-Kućma, M | 1 |
| da Silva Filho, RC; da Silva, AI; de Souza Ferraz, JC; de Souza, SL; Galindo, LCM; Manhães de Castro, R; Matos, RJB; Milanski Ferreira, M; Pinheiro, IL; Reginato, A; Toscano Meneses da Silva Castro, AE | 1 |
| Jiao, Y; Liang, Y; Lin, J; Qu, H; Sun, Y; Xu, J; Zhao, C | 1 |
| Nagano, M; Nagano, R; Nakai, A; Suzuki, H; Takeshita, T | 1 |
| Delafontaine, P; Deo, R; Doerfler, RM; Fink, JC; Fischer, MJ; Jaar, BG; Kramlik, S; Makos, GK; Navaneethan, S; Ojo, A; Slaven, A; Snitker, S; Soliman, EZ; St Peter, WL; Weir, MR; Zhan, M | 1 |
| Chen, XF; Gao, NN; Jin, ZL; Li, XR; Li, YF; Ran, YH; Xiong, J; Zheng, YY | 1 |
| Chon, MW; Chung, S; Kim, HW; Kim, Y; Lee, J | 1 |
| Bhave, S; Faye, A; Gawande, S; Kirpekar, V; Tadke, R | 1 |
| Doboszewska, U; Dudka, J; Herbet, M; Kanadys, A; Korga, A; Ostrowska, M; Poleszak, E; Serefko, A; Świąder, K; Szopa, A; Terlecka, J; Wlaź, A; Wlaź, P; Wośko, S; Wróbel, A; Wyska, E | 1 |
| Kothari, P; Kumar, M; Trivedi, R; Vohora, D; Wadhwa, R | 1 |
| Goulas, A; Krokos, D; Mastrogianni, O; Orphanidis, A; Raikos, N; Tsepa, A; Zisopoulos, K | 1 |
| Bahar, MA; Bos, JHJ; Hak, E; Wang, Y; Wilffert, B | 1 |
| Abou Kassm, S; Naja, W | 1 |
| Xiaoling, Z; Yingdong, L; Yunping, H | 1 |
| Bogdanova, OV; D'Anci, KE; Kanekar, S; Olson, PR; Ombach, HJ; Petersen, M; Renshaw, CE; Renshaw, PF; Sheth, CS; Sung, YH | 1 |
| Asadollahi, M; Karimialavijeh, E; Khanmoradi, Z; Ramezani, M | 1 |
| Carleton, BC; Etminan, M; Guo, MY; Kezouh, A; Kim, DD; Procyshyn, RM; Samii, A | 1 |
| Aguilar-Valles, A; Cao, R; Comai, S; De Gregorio, D; Eslamizade, MJ; Gobbi, G; Haji, N; Lacaille, JC; Luheshi, G; Matta-Camacho, E; Mechawar, N; Nadon, R; Nuñez, N; Popic, J; Rummel, C; Sharma, V; Sonenberg, N; Tanti, A; Turecki, G; Wiebe, S | 1 |
| Gao, YL; He, B | 1 |
| Camsari, DD; Croarkin, PE; Daskalakis, ZJ; Gresbrink, MA; Lewis, CP; Nandakumar, AL; Sonmez, AI | 1 |
| Hong, Y; Joo, YH; Lee, JS; Shon, SH; Yoon, W | 1 |
| Buchanan, GF; Dayton, KG; Kruse, SW; Purnell, BS; Rosner, JI | 1 |
| Alexander, KS; Miller, LL; Patton, TB; Rodriguez, TR; Sarfo, AN | 1 |
| Croarkin, PE; Mills, JA; Strawn, JR | 1 |
| Aitchison, KJ; Binder, EB; Carrillo-Roa, T; Cattaneo, A; DeModena, A; Henigsberg, N; Kelsoe, JR; Leckband, SG; Liu, JJ; McCarthy, M; Mors, O; Ren, H; Rietschel, M; Shekhtman, T; Wei, YB | 1 |
| Assimon, MM; Brookhart, MA; Flythe, JE | 1 |
| Arnold, PD; Bousman, C; Greenslade, A; Maruf, AA | 1 |
| Chen, L; Cheng, S; Guo, S; Xu, H | 1 |
| Bacon, F; Clarke, CS; Donkor, Y; Duffy, L; Freemantle, N; Gilbody, S; Hunter, R; Kendrick, T; Kessler, D; King, M; Lanham, P; Lewis, G; Mangin, D; Marston, L; Moore, M; Nazareth, I; Wiles, N | 1 |
| Handen, BL; Laughlin, SF; Ober, N; Thorkelson, G; Turner, KS | 1 |
| Eriksson, E; Hieronymus, F; Lisinski, A; Nilsson, S | 1 |
| Cheng, X; Dong, W; Feng, W; Li, H; Wang, M; Zhang, D | 1 |
| Doucet, N; Hudon Thibeault, AA; López de Los Santos, Y; Sanderson, JT; Vaillancourt, C | 1 |
| Cen, M; Dai, N; Du, L; Luo, L; Shen, J | 1 |
| Baumann, L; Beedgen, F; Brandt, D; Braunbeck, T; Steiner, M; Stengel, D; Zindler, F | 1 |
| Liao, XM; Si, TM; Su, YA; Wang, Y; Yu, X | 1 |
| Karawekpanyawong, N; Maneeton, B; Maneeton, N; Putthisri, S; Srisurapanon, M; Woottiluk, P | 1 |
| Frecska, E; Mathe, E; More, C; Szoke-Kovacs, R; Szoke-Kovacs, Z | 1 |
| Bonaventure, P; Dugovic, C; Dvorak, C; Liu, C; Lord, B; Lovenberg, T; Wang, L; White, A; Yun, S | 1 |
| Baumann, L; Braunbeck, T; Huhn, C; Knoll, S; Stoll, S; Zindler, F | 1 |
| Flannagan, KS; Kim, K; Mumford, SL; Perkins, NJ; Radoc, JG; Schisterman, EF; Silver, RM; Sjaarda, LA | 1 |
| Coulombe, J; Moodie, EEM; Renoux, C; Shortreed, SM | 1 |
| Hui, A | 1 |
| Eriksson, E; Hieronymus, F; Lisinski, A; Wallerstedt, SM | 1 |
| Chapman, A; Gartlehner, G; Gaynes, BN; Nussbaumer-Streit, B; Probst, T; Sönnichsen, A; Thaler, K; Winkler, D | 1 |
| Bonci, A; Marino, RAM; McDevitt, RA; Tejeda, HA | 1 |
| Kabir, A; Locatelli, M; Morgul, U; Sarıkaya, M; Soylak, M; Tartaglia, A; Ulusoy, HI; Ulusoy, S; Yılmaz, E | 1 |
| Badcock, PB; Bailey, AP; Cox, GR; Hetrick, SE; McKenzie, JE; Meader, N; Merry, SN; Moller, CI; Sharma, V | 1 |
| Aizenman, CD; Garcia, A; Liu, K; Park, JJ; Ramos, L; Toliver, AA | 1 |
| Chmielarz, P; Chorązka, K; Kowalska, M; Kuśmierczyk, J; Nalepa, I; Rafa-Zabłocka, K; Satała, G | 1 |
| Almeida, OP; Hankey, GJ; Jones, JS; Kimata, R | 1 |
| Chen, L; Feng, X; Huang, C; Shen, X; Wang, J; Xu, T | 1 |
| Haas, DM; Marks, C; Quinney, SK; Silvola, R; Teal, E | 1 |
| Aghaeepour, N; Maric, I; Oskotsky, B; Oskotsky, T; Sirota, M; Stevenson, DK; Tang, A; Wong, RJ | 1 |
| Komarov, SD; Severtsev, VV; Vdovin, AS; Vinnikova, MA | 1 |
| Moffat, CF; Petrie, B | 1 |
| Camino, S; Godoy, A; Smith, J; Strejilevich, SA; Szmulewicz, A | 1 |
| Aakjær, M; Andersen, M; Dalhoff, KP; De Bruin, ML; Kristiansen, SB; Pape, K; Sessa, M | 1 |
| Bracke, F; Frieling, H; Leffler, A | 1 |
| Al-Harasis, LM; Albustanji, FH; Kalbouneh, HM; Obaid, YY; Toubasi, AA | 1 |
| Dunham, KE; Venton, BJ | 1 |
| Jauhar, S; Kaufman, KR; Kerr-Gaffney, J; Kurana, S; Strawbridge, R; Yalin, N; Young, AH | 1 |
| Al-Khatib, SM; Assimon, MM; Brookhart, MA; Flythe, JE; Gaynes, BN; Pun, PH; Winkelmayer, WC | 1 |
| Acosta, A; Bielinski, SJ; Camilleri, M; Cifuentes, L; Decker, PA; Gonzalez-Izundegui, D; Hurtado, MD; Moyer, AM; Ricardo-Silgado, ML; Singh, S | 1 |
| Álvarez-Pérez, MA; Bajonero-Domínguez, A; Cruz-Luna, M; Garmendia-Gallardo, C; González-Quiroz, JL; Hernández-Castañón, MY; Hernández-Hernández, VY; Loranca-Moreno, P; Ocampo-Godínez, JM; Rios-Espinosa, A; Sánchez-Tinoco, PM; Vergara Lope-Núñez, JA | 1 |
| Azoulay, L; Cao, TXD; Fergusson, E; Filliter, C; Montastruc, F; Rej, S; Renoux, C; Yu, OHY | 1 |
| Delgado, CP; Nogara, PA; Omage, FB; Teixeira Rocha, JB; Tronco Pauletto, PJ | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K | 1 |
| Denis, P; Hoertel, N; Lemogne, C; Lesuffleur, T; Limosin, F; Ouazana-Vedrines, C; Rachas, A; Tuppin, P | 1 |
| Artursson, P; Blumenfeld, Z; Cohen, BN; Dougherty, DA; Grant, SN; Hammar, R; Kim, CH; Knox, HJ; Lester, HA; Looger, L; Luebbert, L; Marvin, JS; Muthusamy, AK; Nichols, AL; Walton, DP | 1 |
| Asadi-Pooya, AA; Firouzabadi, N; Kashkooli, M; Malekpour, M; Zamiri, B | 1 |
| Holden, JM | 1 |
72 review(s) available for fluoxetine and citalopram
| Article | Year |
|---|---|
Polypharmacology - foe or friend?
Topics: Animals; Communicable Diseases; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Polypharmacology; Safety | 2013 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.
Topics: Allosteric Regulation; Clinical Trials as Topic; Humans; Ligands; Nervous System Diseases; Piperidines; Receptors, sigma; Sigma-1 Receptor; Small Molecule Libraries | 2020 |
Biochemical pharmacology of the serotonin system.
Topics: Alanine; Brain; Citalopram; Clomipramine; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Neurons; Oximes; p-Chloroamphetamine; Paroxetine; Piperidines; Propylamines; Receptors, Serotonin; Reserpine; Serotonin; Serotonin Antagonists; Synapses; Tetrabenazine; Zimeldine | 1986 |
Therapeutic effects of serotonin uptake inhibitors in depression.
Topics: 5-Hydroxytryptophan; Alanine; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Imipramine; Oximes; Paroxetine; Piperidines; Propylamines; Serotonin; Serotonin Antagonists; Trazodone; Zimeldine | 1986 |
Clinical experience with serotonin reuptake inhibiting antidepressants.
Topics: Citalopram; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Oximes; Propylamines; Serotonin Antagonists; Zimeldine | 1987 |
Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.
Topics: 1-Naphthylamine; Animals; Citalopram; Cytochrome P-450 Enzyme System; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stereoisomerism | 1995 |
The pharmacogenetics of the selective serotonin reuptake inhibitors.
Topics: Antidepressive Agents; Citalopram; Cytochrome P-450 Enzyme System; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors | 1993 |
Are pharmacokinetic drug interactions with the SSRIs an issue?
Topics: Antidepressive Agents; Citalopram; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Liver; Selective Serotonin Reuptake Inhibitors | 1996 |
The role of SSRIs in panic disorder.
Topics: 1-Naphthylamine; Citalopram; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients.
Topics: 1-Naphthylamine; Chromatography; Citalopram; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
SSRI safety in overdose.
Topics: Adult; Child; Citalopram; Drug Overdose; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Poison Control Centers; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 1998 |
Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any?
Topics: Animals; Antidepressive Agents, Second-Generation; Calcium Channel Blockers; Citalopram; Dogs; Electrophysiology; Fluoxetine; Guinea Pigs; Heart; Humans; Rabbits; Rats; Selective Serotonin Reuptake Inhibitors; Sodium Channel Blockers | 1999 |
Depression and dementia: comorbidities, identification, and treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Mirtazapine versus selective serotonin reuptake inhibitors.
Topics: Antidepressive Agents, Tricyclic; Citalopram; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Care of depressed patients with anxiety symptoms.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Citalopram; Clinical Trials as Topic; Comorbidity; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Pharmacokinetics of selective serotonin reuptake inhibitors.
Topics: Citalopram; Clinical Trials as Topic; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
Evidence of early onset of antidepressant effect in randomized controlled trials.
Topics: Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Mianserin; Mirtazapine; Personality Inventory; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
The role of selective serotonin reuptake inhibitors in reducing alcohol consumption.
Topics: Alcohol Drinking; Alcoholism; Animals; Behavior, Addictive; Behavior, Animal; Citalopram; Clinical Trials as Topic; Comorbidity; Drinking Behavior; Drug Evaluation, Preclinical; Fluoxetine; Fluvoxamine; Humans; Mice; Rats; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |
Serotonin agents in the treatment of acquired brain injury.
Topics: Brain Injuries; Citalopram; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Injury Severity Score; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2002 |
Enantiomers' potential in psychopharmacology--a critical analysis with special emphasis on the antidepressant escitalopram.
Topics: Animals; Antidepressive Agents, Second-Generation; Citalopram; Depression; Fluoxetine; Humans; Mental Disorders; Mianserin; Molecular Structure; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Stereoisomerism; Thioridazine; Trimipramine | 2002 |
Serotonin syndrome: a brief review.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Diagnosis, Differential; Female; Fluid Therapy; Fluoxetine; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome | 2003 |
[Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
Topics: Antidepressive Agents; Antiparkinson Agents; Bromocriptine; Citalopram; Depressive Disorder; Dopamine Agents; Female; Fluoxetine; Gambling; Humans; Levodopa; Middle Aged; Parkinson Disease | 2003 |
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Citalopram; Clomipramine; Depression; Diagnosis, Differential; Eczema; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Trichotillomania | 2003 |
[Cardiovascular effects of selective serotonin reuptake inhibitor antidepressants].
Topics: Antidepressive Agents, Second-Generation; Calcium Channels; Cardiovascular System; Citalopram; Fluoxetine; Heart; Humans; Ion Channel Gating; Ion Channels; Muscle, Smooth, Vascular; Potassium Channels; Selective Serotonin Reuptake Inhibitors; Sodium Channels | 2004 |
Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
Topics: Autistic Disorder; Citalopram; Clinical Trials as Topic; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Fluoxetine; Fluvoxamine; Humans; Mood Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2005 |
Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
Topics: Citalopram; Cyclohexanols; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Mianserin; Mirtazapine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Trazodone; Venlafaxine Hydrochloride | 2006 |
Pharmacotherapy of child and adolescent depression.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder, Major; Fluoxetine; Humans; Paroxetine; Sertraline; Social Behavior | 2006 |
[Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Second-Generation; Case-Control Studies; Child, Preschool; Citalopram; Confidence Intervals; Depressive Disorder; Family Practice; Female; Fluoxetine; Fluvoxamine; History, Medieval; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Placebos; Psychotherapy; Randomized Controlled Trials as Topic; Risk; Safety; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Suicide; Suicide, Attempted | 2006 |
Treating vasomotor symptoms of menopause: the nurse practitioner's perspective.
Topics: Adrenergic alpha-Agonists; Algorithms; Amines; Citalopram; Clonidine; Complementary Therapies; Cyclohexanecarboxylic Acids; Estrogen Replacement Therapy; Evidence-Based Medicine; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Life Style; Menopause; Middle Aged; Nurse Practitioners; Paroxetine; Patient Education as Topic; Patient Selection; Practice Guidelines as Topic; Primary Health Care; Safety Management; Selective Serotonin Reuptake Inhibitors | 2007 |
Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide | 2007 |
[New developments in hypericum extracts: data on efficacy and interactions].
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bridged Bicyclo Compounds; Child; Citalopram; Depression; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Hypericum; Male; Phloroglucinol; Phytotherapy; Placebos; Plant Extracts; Pregnancy; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Terpenes; Time Factors; Treatment Outcome | 2007 |
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2008 |
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.
Topics: Adult; Citalopram; Female; Fluoxetine; Fluvoxamine; Humans; Odds Ratio; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2008 |
Antidepressant medication use during breastfeeding.
Topics: Antidepressive Agents, Second-Generation; Breast Feeding; Citalopram; Depression, Postpartum; Female; Fluoxetine; Humans; Infant; Lactation; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder.
Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult | 2010 |
Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.
Topics: Citalopram; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Placebo Effect; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
Topics: Abnormalities, Drug-Induced; Cardiovascular Abnormalities; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Maternal-Fetal Exchange; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Teratogens | 2010 |
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
Topics: Adult; Age Factors; Autistic Disorder; Child; Citalopram; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors | 2010 |
[Selective serotonin reuptake inhibitors and mammary pathologies].
Topics: Antidepressive Agents; Breast Neoplasms; Citalopram; Clinical Trials as Topic; Female; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 2010 |
A systematic review of medical treatments for children with autism spectrum disorders.
Topics: Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Child, Preschool; Citalopram; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Female; Fluoxetine; Humans; Male; Patient Compliance; Piperazines; Prognosis; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Serotonin Antagonists; Severity of Illness Index; Treatment Outcome | 2011 |
Second-generation antidepressants for seasonal affective disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Phototherapy; Randomized Controlled Trials as Topic; Reboxetine; Seasonal Affective Disorder; Thiophenes | 2011 |
Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
Topics: Benzofurans; Citalopram; Depressive Disorder; Drug Monitoring; Fluoxetine; Fluvoxamine; Humans; Indoles; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Vilazodone Hydrochloride | 2012 |
Duloxetine versus other anti-depressive agents for depression.
Topics: Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Desvenlafaxine Succinate; Dibenzothiazepines; Duloxetine Hydrochloride; Fluoxetine; Humans; Paroxetine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Thiophenes; Venlafaxine Hydrochloride | 2012 |
Newer generation antidepressants for depressive disorders in children and adolescents.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder; Fluoxetine; Humans; Induction Chemotherapy; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide | 2012 |
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
Topics: Adult; Anxiety; Citalopram; Cognition; Depression; Fluoxetine; Humans; Nervous System Diseases; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stroke; Stroke Rehabilitation | 2012 |
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
Topics: Adult; Age Factors; Autistic Disorder; Child; Child Development Disorders, Pervasive; Citalopram; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors | 2013 |
Selective serotonin reuptake inhibitors for the treatment of irritable bowel syndrome.
Topics: Citalopram; Fluoxetine; Humans; Irritable Bowel Syndrome; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors | 2014 |
The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
Topics: Adult; Aged; Citalopram; Desvenlafaxine Succinate; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vasomotor System; Venlafaxine Hydrochloride | 2015 |
A systematic review of Chinese randomized clinical trials of SSRI treatment of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; China; Citalopram; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Topics: Adrenergic Uptake Inhibitors; Adult; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Norepinephrine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Tension-Type Headache; Venlafaxine Hydrochloride | 2015 |
Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
Topics: Amitriptyline; Citalopram; Fibromyalgia; Fluoxetine; Humans; Melatonin; Musculoskeletal Pain; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Syndrome | 2015 |
Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder.
Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2016 |
Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Topics: Antidepressive Agents; Atorvastatin; Citalopram; Depressive Disorder, Major; Double-Blind Method; Fluoxetine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Randomized Controlled Trials as Topic; Simvastatin; Treatment Outcome | 2016 |
Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis.
Topics: Adult; Antidepressive Agents; Citalopram; Depression; Fluoxetine; Humans; Kidney Failure, Chronic; Psychotherapy; Quality of Life; Randomized Controlled Trials as Topic; Renal Dialysis; Sertraline | 2016 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Topics: Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Citalopram; Depression; Depressive Disorder, Major; Drug Combinations; Fluoxetine; Humans; Inositol; Lamotrigine; Lithium; Triazines; Vitamin B Complex | 2016 |
Antidepressant pharmacogenetics in children and young adults: A systematic review.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mental Disorders; Nortriptyline; Paroxetine; Pharmacogenetics; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tryptophan Hydroxylase; Venlafaxine Hydrochloride; Young Adult | 2019 |
Comparative cardiovascular safety of selective serotonin reuptake inhibitors (SSRIs) among Chinese senile depression patients: A network meta-analysis of randomized controlled trials.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Asian People; Cardiovascular Diseases; China; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2019 |
Selective Serotonin Reuptake Inhibitor Monotherapy for Anxiety Disorders in Children and Adolescents with Autism Spectrum Disorder: A Chart Review.
Topics: Adolescent; Anxiety Disorders; Autism Spectrum Disorder; Citalopram; Comorbidity; Female; Fluoxetine; Humans; Male; Retrospective Studies; Selective Serotonin Reuptake Inhibitors | 2019 |
Fluoxetine in acute treatment of children and adolescents with obsessive-compulsive disorder: a systematic review and meta-analysis.
Topics: Adolescent; Child; Citalopram; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Prospective Studies; Research Design; Treatment Outcome | 2020 |
Exploring the utility of RDoC in differentiating effectiveness amongst antidepressants: A systematic review using proposed psychometrics as the unit of analysis for the Negative Valence Systems domain.
Topics: Algorithms; Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depressive Disorder; Desvenlafaxine Succinate; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Psychometrics; Sertraline; Treatment Outcome | 2020 |
Second-generation antidepressants for treatment of seasonal affective disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Bias; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Observational Studies as Topic; Phototherapy; Placebos; Quality of Life; Randomized Controlled Trials as Topic; Reboxetine; Seasonal Affective Disorder; Thiophenes; Treatment Outcome | 2021 |
New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Antidepressive Agents; Bias; Child; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mirtazapine; Network Meta-Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicidal Ideation; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2021 |
Risk of Fractures in Stroke Patients Treated With a Selective Serotonin Reuptake Inhibitor: A Systematic Review and Meta-Analysis.
Topics: Citalopram; Depression; Fluoxetine; Fractures, Bone; Humans; Selective Serotonin Reuptake Inhibitors; Stroke | 2021 |
Recent sample pretreatment methods for determination of selective serotonin reuptake inhibitors (SSRIs) in biological samples.
Topics: Citalopram; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2021 |
Are all antidepressants the same? The consumer has a point.
Topics: Antidepressive Agents; Bupropion; Citalopram; Fluoxetine; Humans; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2023 |
Safety and Efficacy of SSRIs in Improving Poststroke Recovery: A Systematic Review and Meta-Analysis.
Topics: Anxiety; Citalopram; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Stroke; United States | 2022 |
A systematic review and meta-analysis of treatments for rapid cycling bipolar disorder.
Topics: Aripiprazole; Bipolar Disorder; Citalopram; Fluoxetine; Humans; Lamotrigine; Olanzapine; Quetiapine Fumarate; Venlafaxine Hydrochloride | 2022 |
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
40 trial(s) available for fluoxetine and citalopram
| Article | Year |
|---|---|
Clinical experience with serotonin reuptake inhibiting antidepressants.
Topics: Citalopram; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Oximes; Propylamines; Serotonin Antagonists; Zimeldine | 1987 |
The new generation antidepressants: promising innovations or disappointments?
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Depressive Disorder; Dopamine; Drug Evaluation; Fluoxetine; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Receptors, Neurotransmitter; Serotonin; Trazodone; Zimeldine | 1985 |
Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Nausea; Selective Serotonin Reuptake Inhibitors | 1996 |
Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Caffeine; Chromatography, High Pressure Liquid; Citalopram; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Male; Mephenytoin; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sparteine | 1996 |
Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
Topics: Adult; Aged; Ambulatory Care; Buspirone; Citalopram; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Finland; Fluoxetine; Humans; Male; Middle Aged; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2001 |
Citalopram treatment of fluoxetine nonresponders.
Topics: Adult; Ambulatory Care; Citalopram; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |
Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States | 2002 |
Citalopram treatment of fluoxetine-intolerant depressed patients.
Topics: Adult; Aged; Citalopram; Depressive Disorder; Drug Tolerance; Female; Fluoxetine; Headache; Humans; Male; Middle Aged; Placebos; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Single-Blind Method; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2003 |
Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Area Under Curve; Citalopram; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Double-Blind Method; Drug Interactions; Fluoxetine; Half-Life; Humans | 2003 |
Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors.
Topics: Adult; Antioxidants; Ascorbic Acid; Citalopram; Depression; Female; Fluoxetine; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Superoxide Dismutase; Time Factors | 2003 |
Therapeutic drug monitoring of trazodone: are there pharmacokinetic interactions involving citalopram and fluoxetine?
Topics: Adult; Antidepressive Agents; Citalopram; Drug Interactions; Drug Monitoring; Female; Fluoxetine; Humans; Male; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Trazodone | 2004 |
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
Topics: Adult; Ambulatory Care; Citalopram; Clomipramine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Obesity; Obsessive-Compulsive Disorder; Paroxetine; Patient Compliance; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2004 |
Dopaminergic mechanism of antidepressant action in depressed patients.
Topics: Adult; Affect; Case-Control Studies; Citalopram; Depressive Disorder, Major; Dopamine Antagonists; Female; Fluoxetine; Humans; Male; Middle Aged; Motor Activity; Paroxetine; Receptors, Dopamine D2; Receptors, Dopamine D3; Selective Serotonin Reuptake Inhibitors; Sulpiride; Treatment Outcome | 2005 |
Escitalopram in the treatment of depressed elderly patients.
Topics: Aged; Aged, 80 and over; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors | 2005 |
Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
Topics: Adolescent; Adult; Aged; Asian People; China; Citalopram; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Fluoxetine; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Patient Compliance; Personality Inventory; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2008 |
Effect of serotonergic antidepressant therapy on temperament and character scales in patients with chronic tension-type headache.
Topics: Adult; Character; Chronic Disease; Citalopram; Female; Fluoxetine; Harm Reduction; Humans; Internal-External Control; Male; Paroxetine; Personal Autonomy; Personality Inventory; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Temperament; Tension-Type Headache | 2007 |
Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Thiophenes; Treatment Outcome | 2007 |
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.
Topics: Adolescent; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment | 2008 |
The effects of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study.
Topics: Adolescent; Adult; Citalopram; Double-Blind Method; Ejaculation; Erectile Dysfunction; Fluoxetine; Humans; Male; Penile Erection; Penis; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Surveys and Questionnaires; Time Factors; Young Adult | 2008 |
The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Quinolones; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2010 |
Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules.
Topics: Adult; Aged; Aorta; Cell Adhesion; Cell Survival; Chronic Disease; Citalopram; Depression; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Fluoxetine; Fluvoxamine; Heart Failure; Humans; Intercellular Adhesion Molecule-1; Middle Aged; Monocytes; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Tumor Necrosis Factor-alpha; U937 Cells; Vascular Cell Adhesion Molecule-1 | 2010 |
A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).
Topics: Adolescent; Child; Citalopram; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires | 2009 |
Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
Topics: Adolescent; Antidepressive Agents; Benzodiazepines; Citalopram; Cognitive Behavioral Therapy; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Suicide; Suicide, Attempted; Venlafaxine Hydrochloride | 2009 |
A short duration of untreated illness (DUI) improves response outcomes in first-depressive episodes.
Topics: Adult; Citalopram; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Humans; Male; Pindolol; Recurrence; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2010 |
Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Time Factors; Vascular Endothelial Growth Factor A; Young Adult | 2009 |
Salvage use of citalopram for treatment of fluoxetine-resistant premature ejaculation in recently married men: a prospective clinical trial.
Topics: Adult; Citalopram; Drug Resistance; Ejaculation; Fluoxetine; Humans; Male; Marriage; Patient Satisfaction; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Time Factors; Young Adult | 2010 |
Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) study.
Topics: Adolescent; Age Factors; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Treatment Outcome | 2011 |
Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram?
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Blood Glucose; Chi-Square Distribution; Citalopram; Depression; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fluoxetine; Glycated Hemoglobin; Humans; Lipids; Male; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies; Treatment Outcome | 2011 |
Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial.
Topics: Adult; Citalopram; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Fructose; Humans; Male; Neuroprotective Agents; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Topiramate | 2011 |
Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression.
Topics: Adolescent; Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Cytokines; Depressive Disorder, Major; Dietary Supplements; Double-Blind Method; Female; Fluoxetine; Humans; Interleukin-6; Iran; Male; Middle Aged; Placebos; Selective Serotonin Reuptake Inhibitors; Tumor Necrosis Factor-alpha; Zinc | 2014 |
Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
Topics: Adolescent; Anxiety; Attention Deficit and Disruptive Behavior Disorders; Behavioral Symptoms; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Fluoxetine; Humans; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
The bidirectional relationship between body mass index and treatment outcome in adolescents with treatment-resistant depression.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Body Mass Index; Child; Citalopram; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial.
Topics: Adult; Carotenoids; Citalopram; Crocus; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Iran; Male; Middle Aged; Phytotherapy; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch.
Topics: Adult; Antidepressive Agents; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Female; Fluoxetine; Genotype; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Venlafaxine Hydrochloride | 2016 |
Analysis of curative effect of fluoxetine and escitalopram in the depression treatment based on clinical observation.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Cytokines; Depression; Female; Fluoxetine; Gene Expression Regulation; Humans; Inflammation; Male | 2018 |
The efficacy comparison of citalopram, fluoxetine, and placebo on motor recovery after ischemic stroke: a double-blind placebo-controlled randomized controlled trial.
Topics: Citalopram; Disability Evaluation; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Physical Therapy Modalities; Selective Serotonin Reuptake Inhibitors; Stroke | 2018 |
A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRes
Topics: Adult; Aged; Antidepressive Agents; Citalopram; Cost-Benefit Analysis; Depression; Double-Blind Method; Fluoxetine; Humans; Middle Aged; Mirtazapine; Outcome Assessment, Health Care; Primary Health Care; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Sample Size; Sertraline | 2019 |
[Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study].
Topics: Alcoholism; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2021 |
Citalopram improves vasomotor syndrome and urogenital syndrome of menopause in Mexican women: a randomized clinical trial.
Topics: Citalopram; Female; Fluoxetine; Humans; Menopause; Postmenopause; Prospective Studies; Syndrome | 2022 |
342 other study(ies) available for fluoxetine and citalopram
| Article | Year |
|---|---|
Structure-activity relationships for a novel series of citalopram (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile) analogues at monoamine transporters.
Topics: Amino Acid Transport Systems; Animals; Bacterial Proteins; Binding, Competitive; Brain; Citalopram; Dopamine Plasma Membrane Transport Proteins; In Vitro Techniques; Leucine; Ligands; Models, Molecular; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Radioligand Assay; Rats; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism; Structure-Activity Relationship | 2010 |
Pyrroloisoquinoline antidepressants. 3. A focus on serotonin.
Topics: Animals; Antidepressive Agents; Biological Assay; Biological Transport; Dose-Response Relationship, Drug; Isoquinolines; Mice; Pyrroles; Rats; Serotonin; Structure-Activity Relationship | 1990 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 1.
Topics: Animals; Binding, Competitive; Carrier Proteins; Cell Membrane; Cerebral Cortex; Citalopram; Drug Design; Indicators and Reagents; Kinetics; Membrane Glycoproteins; Membrane Transport Proteins; Models, Structural; Molecular Conformation; Nerve Tissue Proteins; Quipazine; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship | 2000 |
Inhibition of P-glycoprotein by newer antidepressants.
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Endothelium, Vascular; Humans; Reproducibility of Results; Swine; Transfection | 2003 |
Carbonic anhydrase activators. The selective serotonin reuptake inhibitors fluoxetine, sertraline and citalopram are strong activators of isozymes I and II.
Topics: Brain; Carbonic Anhydrase I; Carbonic Anhydrase II; Citalopram; Crystallography, X-Ray; Enzyme Activation; Enzyme Activators; Fluoxetine; Histamine; Phenylalanine; Selective Serotonin Reuptake Inhibitors; Sertraline; Structure-Activity Relationship | 2003 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats | 2007 |
Synthesis of some tropane derivatives of anticipated activity on the reuptake of norepinephrine and/or serotonin.
Topics: 5-Hydroxytryptophan; Adrenergic alpha-Antagonists; Animals; Citalopram; Clomipramine; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoxetine; Mice; Molecular Structure; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tropanes; Yohimbine | 2007 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.
Topics: Animals; Benzofurans; Blood Platelets; Brain; Cell Line; Citalopram; Humans; In Vitro Techniques; Norepinephrine Plasma Membrane Transport Proteins; Propylamines; Rats; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Synaptosomes | 2008 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Fluorescent reporters of monoamine transporter distribution and function.
Topics: Animals; Blood Pressure; Cell Line; Fluorescent Dyes; Isoquinolines; Mice; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Spectrophotometry, Ultraviolet | 2011 |
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics | 2012 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands - Fluoxetine and fluvoxamine.
Topics: Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Ligands; Models, Molecular; Molecular Structure; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship | 2021 |
Potentiation of 5-hydroxytryptamine-induced contraction in rat aorta by chlorpheniramine, citalopram and fluoxetine.
Topics: Animals; Aorta, Thoracic; Chlorpheniramine; Citalopram; Cocaine; Dose-Response Relationship, Drug; Fluoxetine; Histamine H1 Antagonists; Imipramine; In Vitro Techniques; Male; Pargyline; Rats; Rats, Sprague-Dawley; Serotonin; Vasoconstriction | 1992 |
Effects of inhibitors of neuronal uptake of 5-HT on sympathetic cardiovascular regulation.
Topics: Analysis of Variance; Animals; Blood Platelets; Blood Pressure; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Heart Rate; Norepinephrine; Rabbits; Serotonin; Sympathetic Nervous System | 1992 |
The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sparteine | 1992 |
The effect of antidepressant drugs on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist.
Topics: Animals; Antidepressive Agents; Benzazepines; Citalopram; Dizocilpine Maleate; Fluoxetine; Imipramine; Isomerism; Male; Maprotiline; Motor Activity; Prazosin; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Seizures; Sulpiride | 1992 |
Serotonergic modulation of footshock induced aggression in paired rats.
Topics: 5-Hydroxytryptophan; Aggression; Agonistic Behavior; Animals; Apomorphine; Citalopram; Clorgyline; Drug Interactions; Electroshock; Female; Fenclonine; Fluoxetine; Foot; Ketanserin; Male; Metergoline; Quipazine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1991 |
High- and low-affinity [3H]desipramine-binding sites in human postmortem brain tissue.
Topics: Adult; Aged; Aged, 80 and over; Animals; Brain; Carrier Proteins; Citalopram; Cricetinae; Desipramine; Female; Fluoxetine; Humans; Male; Middle Aged; Norepinephrine; Radioligand Assay; Receptors, Drug; Receptors, Neurotransmitter | 1990 |
Inhibition of mouse killing behavior by serotonin-mimetic drugs: effects of partial alterations of serotonin neurotransmission.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aggression; Animals; Citalopram; Fenclonine; Fluoxetine; Hydroxyindoleacetic Acid; Male; Methoxydimethyltryptamines; Motor Activity; Propylamines; Raphe Nuclei; Rats; Rats, Inbred Strains; Serotonin; Tetrahydronaphthalenes | 1987 |
A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
Topics: Animals; Antidepressive Agents, Tricyclic; Binding Sites; Binding, Competitive; Biological Transport; Cerebral Cortex; Citalopram; Dose-Response Relationship, Drug; Ethylmaleimide; Fluoxetine; Imipramine; Male; Neurons; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Sodium | 1989 |
Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Cerebral Cortex; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; Ketanserin; Kinetics; Male; Methiothepin; N-Methyl-3,4-methylenedioxyamphetamine; Piperonyl Butoxide; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Tryptophan Hydroxylase | 1987 |
The effect of selective 5-hydroxytryptamine uptake inhibitors on 5-methoxy-N,N-dimethyltryptamine-induced ejaculation in the rat.
Topics: Alanine; Animals; Behavior, Animal; Citalopram; Ejaculation; Fluoxetine; Male; Metergoline; Methoxydimethyltryptamines; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Time Factors; Zimeldine | 1986 |
Characterization of [3H]paroxetine binding in rat brain.
Topics: Animals; Binding, Competitive; Brain; Cell Membrane; Cerebral Cortex; Citalopram; Fluoxetine; Imipramine; Male; Paroxetine; Peptide Hydrolases; Piperidines; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Tritium | 1988 |
Interactions of 5HT reuptake inhibitors and ethanol in tests of exploration and anxiety.
Topics: Animals; Anxiety; Citalopram; Desipramine; Drug Interactions; Ethanol; Exploratory Behavior; Fluoxetine; Fluvoxamine; Mice; Mice, Inbred Strains; Motor Activity; Oximes; Serotonin Antagonists | 1988 |
Behavioral interactions of fluoxetine and other 5-hydroxytryptamine uptake inhibitors with ethanol in tests of anxiety, locomotion and exploration.
Topics: Animals; Anxiety; Citalopram; Desipramine; Ethanol; Exploratory Behavior; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Oximes; Serotonin Antagonists | 1988 |
The mechanism by which monoamine oxidase inhibitors give rise to a non-calcium-dependent component in the depolarization-induced release of 5-HT from rat brain synaptosomes.
Topics: Animals; Brain; Calcium; Citalopram; Clomipramine; Fluoxetine; Male; Monoamine Oxidase Inhibitors; Nialamide; Pargyline; Potassium; Rats; Rats, Inbred Strains; Serotonin; Synaptosomes | 1988 |
Serotonin uptake inhibitors and the prejunctional effects of serotonin on peripheral sympathetic nerves.
Topics: Animals; Atropine; Biological Transport, Active; Cats; Citalopram; Fluoxetine; Guinea Pigs; Heart Atria; Muscle Contraction; Myocardial Contraction; Nictitating Membrane; Norepinephrine; Peripheral Nerves; Propylamines; Serotonin; Serotonin Antagonists | 1986 |
Failure to detect any transport of the irreversible monoamine oxidase inhibitor N-cyclopropyl-4-chloroamphetamine by the carrier of 5-hydroxytryptamine in the brain of the rat in vivo.
Topics: Amphetamines; Animals; Cell Membrane Permeability; Citalopram; Fluoxetine; Hypothalamus; In Vitro Techniques; Male; Monoamine Oxidase Inhibitors; Nerve Endings; p-Chloroamphetamine; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Synaptosomes | 1986 |
Analgesic properties of intrathecally administered heterocyclic antidepressants.
Topics: Analgesics; Animals; Antidepressive Agents; Citalopram; Desipramine; Dibenzocycloheptenes; Fluoxetine; Injections, Spinal; Male; Mice; Propylamines; Protriptyline | 1987 |
The effect of selective inhibitors of noradrenaline and serotonin uptake on reserpine- and apomorphine induced hypothermia in mice.
Topics: Animals; Apomorphine; Body Temperature; Citalopram; Desipramine; Fluoxetine; Male; Maprotiline; Mice; Norepinephrine; Propylamines; Reserpine; Serotonin Antagonists | 1983 |
Evidence that the medial and dorsal raphe nuclei mediate serotonergically-induced increases in prolactin release from the pituitary.
Topics: Animals; Brain Mapping; Brain Stem; Citalopram; Dopamine; Fluoxetine; Male; Median Eminence; Neural Pathways; Pituitary Gland, Anterior; Prolactin; Propylamines; Raphe Nuclei; Rats; Rats, Inbred Strains; Serotonin | 1984 |
Effects of 6-methoxy-1,2,3,4-tetrahydro-beta-carboline (6-MeO-THbetaC) on audiogenic seizures in DBA/2J mice.
Topics: 5-Hydroxytryptophan; Acoustic Stimulation; Animals; Benzofurans; Carbolines; Citalopram; Clomipramine; Clorgyline; Fluoxetine; Harmine; Indoles; Methoxydimethyltryptamines; Mice; Mice, Inbred DBA; N,N-Dimethyltryptamine; Pargyline; Propylamines; Quipazine; Seizures; Selegiline | 1980 |
Effects of chronic treatment with antidepressants on aggressiveness induced by clonidine in mice.
Topics: Aggression; Animals; Antidepressive Agents; Citalopram; Clonidine; Drug Interactions; Fluoxetine; Flupenthixol; Fluvoxamine; Humans; Male; Mice; Oximes; Pizotyline; Propylamines; Stereoisomerism | 1982 |
Effects of norepinephrine and 5-hydroxytryptamine reuptake inhibitors on electrically-induced spinal cord seizures in rats.
Topics: Animals; Benzofurans; Citalopram; Desipramine; Electric Stimulation; Female; Fluoxetine; Norepinephrine; Propylamines; Rats; Seizures; Serotonin Antagonists; Spinal Cord | 1980 |
Interaction of cholinergic and dopaminergic influences on yawning behavior.
Topics: Animals; Apomorphine; Behavior, Animal; Benzofurans; Citalopram; Fluoxetine; Metergoline; Physostigmine; Propylamines; Rats; Receptors, Cholinergic; Receptors, Dopamine; Scopolamine; Spiperone | 1980 |
Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas.
Topics: Animals; Cell Division; Cell Line; Citalopram; Colonic Neoplasms; Epithelium; Fluoxetine; Intestines; Male; Neoplasm Transplantation; Neoplasms, Experimental; Propylamines; Rats; Rats, Inbred Strains; Rectal Neoplasms; Serotonin Antagonists | 1982 |
Hair loss associated with fluoxetine but not with citalopram.
Topics: Alopecia; Bipolar Disorder; Citalopram; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors | 1995 |
Behavioural profile of two potential antidepressant pyridazine derivatives including arylpiperazinyl moieties in their structure, in mice.
Topics: 5-Hydroxytryptophan; Analgesia; Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Blepharoptosis; Citalopram; Clomipramine; Drug Interactions; Fluoxetine; Hypothermia; Imipramine; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Models, Molecular; Motor Activity; Naloxone; Piperazines; Pyridazines; Reserpine; Structure-Activity Relationship; Swimming; Trazodone; Yohimbine | 1995 |
Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
Topics: 1-Naphthylamine; 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Aggression; Analysis of Variance; Animals; Behavior, Animal; Brain; Citalopram; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Fluvoxamine; Male; Mice; Paroxetine; Penbutolol; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Sertraline; Synaptosomes | 1994 |
Comparison of (R)-[3H]tomoxetine and (R/S)-[3H]nisoxetine binding in rat brain.
Topics: Animals; Atomoxetine Hydrochloride; Autoradiography; Binding Sites; Brain; Citalopram; Desipramine; Fluoxetine; Male; Norepinephrine; Propylamines; Rats; Rats, Sprague-Dawley; Stereoisomerism; Tritium | 1995 |
Carbon-11-cocaine binding compared at subpharmacological and pharmacological doses: a PET study.
Topics: Animals; Binding Sites; Brain; Carbon Radioisotopes; Carrier Proteins; Cerebellum; Citalopram; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Fluoxetine; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine; Papio; Serotonin; Tomography, Emission-Computed | 1995 |
Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments.
Topics: Adrenergic beta-1 Receptor Agonists; Animals; Autoradiography; Brain Chemistry; Citalopram; Fluoxetine; Image Processing, Computer-Assisted; Imipramine; Iodocyanopindolol; Male; Pindolol; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Up-Regulation | 1994 |
Effects of locally applied cocaine, lidocaine, and various uptake blockers on monoamine transmission in the ventral tegmental area of freely moving rats: a microdialysis study on monoamine interrelationships.
Topics: Animals; Biogenic Monoamines; Citalopram; Cocaine; Desipramine; Dopamine; Dose-Response Relationship, Drug; Fluoxetine; Lidocaine; Ligands; Male; Microdialysis; Movement; Norepinephrine; Piperazines; Rats; Serotonin; Tetrodotoxin; Ventral Tegmental Area | 1994 |
Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.
Topics: Animals; Antidepressive Agents; Binding Sites; Brain; Citalopram; Fluoxetine; Ketanserin; Male; Maprotiline; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin | 1994 |
Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference.
Topics: Alcohol Drinking; Alcoholism; Animals; Buspirone; Chlordiazepoxide; Citalopram; Dose-Response Relationship, Drug; Drinking; Fluoxetine; Male; Ondansetron; Rats; Receptors, Serotonin; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |
Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area.
Topics: Animals; Citalopram; Dopamine; Dose-Response Relationship, Drug; Electrophysiology; Fluoxetine; Injections, Intravenous; Male; Neurons; Rats; Rats, Sprague-Dawley; Substantia Nigra; Time Factors; Ventral Tegmental Area | 1995 |
The effects of selective serotonin reuptake inhibitors and their metabolites on S-mephenytoin 4'-hydroxylase activity in human liver microsomes.
Topics: Aryl Hydrocarbon Hydroxylases; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme Inhibitors; Fluoxetine; Humans; Kinetics; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1995 |
In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies.
Topics: Adrenergic Uptake Inhibitors; Animals; Carrier Proteins; Cerebral Cortex; Citalopram; Clonidine; Desipramine; Fluoxetine; Fluvoxamine; Imipramine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Raphe Nuclei; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters | 1996 |
Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexus.
Topics: Amphetamines; Animals; Antiparkinson Agents; Autoradiography; Choroid Plexus; Citalopram; Ergolines; Fluoxetine; Image Processing, Computer-Assisted; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Up-Regulation | 1996 |
Antidepressant induced mania in obsessive compulsive disorder.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Citalopram; Clomipramine; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder | 1996 |
Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor.
Topics: Animals; Antidepressive Agents, Tricyclic; Choroid Plexus; Citalopram; Fluoxetine; Imipramine; Male; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors | 1996 |
Predicting value of tryptophan/large neutral amino acids ratio on selective serotonin reuptake inhibitors.
Topics: Amino Acids; Antidepressive Agents; Biomarkers; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Tryptophan | 1996 |
Increased noradrenaline efflux induced by local infusion of fluoxetine in the rat frontal cortex.
Topics: Adrenergic Uptake Inhibitors; Animals; Benzylamines; Citalopram; Desipramine; Fluoxetine; Frontal Lobe; In Vitro Techniques; Injections; Male; Microdialysis; Norepinephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Synaptosomes | 1996 |
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
Topics: 1-Naphthylamine; Aggression; Animals; Anxiety; Binding, Competitive; Citalopram; Depression; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Rats; Rats, Wistar; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sertraline; Vocalization, Animal | 1997 |
Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat.
Topics: 1-Naphthylamine; Animals; Behavior, Animal; Chlorpromazine; Citalopram; Fluoxetine; Fluvoxamine; Guanidines; Haloperidol; Male; Microinjections; Motor Activity; Paroxetine; Piperidines; Posture; Rats; Rats, Sprague-Dawley; Receptors, sigma; Red Nucleus; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
An affinity-modulating site on neuronal monoamine transport proteins.
Topics: 1-Naphthylamine; Animals; Binding Sites; Biogenic Monoamines; Cerebral Cortex; Citalopram; Corpus Striatum; Female; Fluoxetine; In Vitro Techniques; Kinetics; Neurons; Piperazines; Rats; Receptors, Neurotransmitter; Sertraline; Stereoisomerism | 1997 |
Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test.
Topics: Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Desipramine; Drug Interactions; Fluoxetine; Fluvoxamine; Imipramine; Ketanserin; Male; Maprotiline; Mice; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming | 1997 |
Pharmacological studies on YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT2A receptor antagonistic activity.
Topics: Animals; Citalopram; Fluoxetine; Learning; Mice; Mice, Inbred ICR; Morpholines; Olfactory Bulb; Oxotremorine; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Tremor | 1997 |
Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats.
Topics: Animals; Autoradiography; Cerebral Cortex; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Granisetron; Hippocampus; Male; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Receptors, Serotonin, 5-HT4; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptosomes | 1997 |
Release and uptake rates of 5-hydroxytryptamine in the dorsal raphe and substantia nigra reticulata of the rat brain.
Topics: Adrenergic Uptake Inhibitors; Animals; Autoradiography; Calcium; Citalopram; Dopamine; Electric Stimulation; Electrochemistry; Evoked Potentials; Fluoxetine; Male; Microelectrodes; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Substantia Nigra; Tetrabenazine; Tritium | 1998 |
Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors.
Topics: 2-Amino-5-phosphonovalerate; Adaptation, Physiological; Animals; Binding, Competitive; Cerebral Cortex; Citalopram; Excitatory Amino Acid Antagonists; Fluoxetine; Glycine; Male; Mice; Radioligand Assay; Receptors, N-Methyl-D-Aspartate; Selective Serotonin Reuptake Inhibitors | 1998 |
Selective serotonin reuptake inhibitors potentiate 8-OH-DPAT-induced stimulus control in the pigeon.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Citalopram; Columbidae; Conditioning, Operant; Discrimination, Psychological; Drug Synergism; Fluoxetine; Generalization, Stimulus; Imipramine; Male; Neurotransmitter Uptake Inhibitors; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 1998 |
The effect of antidepressants on rat aggressive behavior in the electric footshock and apomorphine-induced aggressiveness paradigms.
Topics: Aggression; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Apomorphine; Citalopram; Desipramine; Dopamine Agents; Electroshock; Fluoxetine; Levodopa; Male; Pain Measurement; Rats; Rats, Wistar; Tryptophan | 1998 |
The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Anti-Arrhythmia Agents; Child; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Kinetics; Male; Methylation; Metoprolol; Microsomes, Liver; Oxidation-Reduction; Paroxetine; Quinidine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Antidepressive Agents, Second-Generation; Citalopram; Conditioning, Operant; Discrimination, Psychological; Fluoxetine; Indans; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 1998 |
Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
Topics: Animals; Antidepressive Agents; Buspirone; Citalopram; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exercise Test; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming | 1998 |
Evidence from microdialysis and synaptosomal studies of rat cortex for noradrenaline uptake sites with different sensitivities to SSRIs.
Topics: 5,7-Dihydroxytryptamine; Animals; Antidepressive Agents, Tricyclic; Benzylamines; Citalopram; Desipramine; Fluoxetine; Frontal Lobe; Male; Microdialysis; Norepinephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Synaptosomes | 1998 |
Carbamazepine-induced release of serotonin from rat hippocampus in vitro.
Topics: Animals; Anticonvulsants; Carbamazepine; Carrier Proteins; Citalopram; Fluoxetine; Hippocampus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Synaptosomes | 1998 |
Using secondary binding properties to select a not so selective serotonin reuptake inhibitor.
Topics: Adolescent; Adult; Child; Citalopram; Cytochrome P-450 Enzyme System; Drug Prescriptions; Fluoxetine; Fluvoxamine; Humans; Mental Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Effects of acute and chronic antidepressant administration on phencyclidine (PCP) induced locomotor hyperactivity.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Excitatory Amino Acid Antagonists; Fluoxetine; Male; Motor Activity; Paroxetine; Phencyclidine; Rats; Rats, Sprague-Dawley | 1999 |
Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats.
Topics: Alcohol Drinking; Alcoholism; Animals; Citalopram; Disease Models, Animal; Eating; Ethanol; Female; Fluoxetine; Fluvoxamine; Food Preferences; Male; Paroxetine; Rats; Rats, Mutant Strains; Selective Serotonin Reuptake Inhibitors | 1999 |
Citalopram and sexual side effects of selective serotonin reuptake inhibitors.
Topics: Aged; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Treatment Outcome | 1999 |
Molecular cloning, expression and characterization of a bovine serotonin transporter.
Topics: Amino Acid Sequence; Animals; Carrier Proteins; Cattle; Citalopram; Cloning, Molecular; Desipramine; Female; Fluoxetine; HeLa Cells; Humans; Imipramine; Kinetics; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Sequence Data; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Organ Specificity; Paroxetine; Phylogeny; Pregnancy; Rats; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Sequence Alignment; Sequence Homology, Amino Acid; Serotonin; Serotonin Plasma Membrane Transport Proteins; Transfection | 1999 |
Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram.
Topics: Aminopyridines; Animals; Biogenic Monoamines; Citalopram; Dopamine; Extracellular Space; Fenclonine; Fluoxetine; Indoles; Injections, Intraperitoneal; Male; Microdialysis; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 1999 |
Excretion of paroxetine into breast milk.
Topics: Adult; Breast Feeding; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Fluvoxamine; Humans; Lactation; Milk, Human; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Triglycerides | 1999 |
Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection.
Topics: Acetonitriles; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Humans; Hydrogen-Ion Concentration; Paroxetine; Quality Control; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 1999 |
Nitrogen-based drugs are not essential for blockade of monoamine transporters.
Topics: Animals; Binding Sites; Carrier Proteins; Citalopram; Cocaine; COS Cells; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; Humans; Macaca fascicularis; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nitrogen; Norepinephrine; Putamen; Radioligand Assay | 1996 |
Effect of acute treatment with YM992 on extracellular serotonin levels in the rat frontal cortex.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Cerebral Cortex; Citalopram; Cyclohexanols; Dose-Response Relationship, Drug; Extracellular Space; Fluorobenzenes; Fluoxetine; Frontal Lobe; Male; Morpholines; p-Chloroamphetamine; Piperidines; Rats; Rats, Wistar; Serotonin; Serotonin Agents; Serotonin Antagonists; Synaptosomes; Tritium; Venlafaxine Hydrochloride | 2000 |
Effect of acute treatment with YM992 on extracellular norepinephrine levels in the rat frontal cortex.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Citalopram; Cyclohexanols; Dose-Response Relationship, Drug; Extracellular Space; Fluorobenzenes; Fluoxetine; Frontal Lobe; Male; Morpholines; Norepinephrine; Piperidines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Venlafaxine Hydrochloride | 2000 |
Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study.
Topics: Animals; Antidepressive Agents; Autoradiography; Brain Chemistry; Carrier Proteins; Citalopram; Cyclohexanols; Desipramine; Fluoxetine; Gene Expression Regulation; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Organ Specificity; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins; Stereotaxic Techniques; Symporters; Trimipramine; Venlafaxine Hydrochloride | 2001 |
Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated.
Topics: 5,7-Dihydroxytryptamine; Animals; Citalopram; Corpus Striatum; Dopamine; Fluoxetine; Hippocampus; Hydroxyindoleacetic Acid; Male; Microdialysis; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Substantia Nigra | 2000 |
Determination of four selective serotonin reuptake inhibitors by capillary isotachophoresis.
Topics: Citalopram; Electrophoresis, Capillary; Fluoxetine; Fluvoxamine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice.
Topics: Analysis of Variance; Animals; Citalopram; Cytokines; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoxetine; Immunity, Cellular; Interferon-gamma; Interleukin-1; Interleukin-10; Interleukin-2; Interleukin-4; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Selective Serotonin Reuptake Inhibitors | 2000 |
Female sexual dysfunction and antidepressant use.
Topics: Amantadine; Antidepressive Agents; Buspirone; Citalopram; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Meta-Analysis as Topic; Paroxetine; Personality Inventory; Placebos; Sexual Dysfunctions, Psychological; Treatment Outcome | 2001 |
Costs and outcomes of use of amitriptyline, citalopram and fluoxetine in major depression: exploratory study.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Citalopram; Czech Republic; Depressive Disorder; Drug Costs; Female; Fluoxetine; Humans; Male; Middle Aged; Treatment Outcome | 2000 |
[Indications for antidepressive medication].
Topics: Antidepressive Agents; Citalopram; Fluoxetine; Humans; Panic Disorder; Sensitivity and Specificity | 1997 |
Does mirtazapine have a more rapid onset than SSRIs?
Topics: Antidepressive Agents, Tricyclic; Citalopram; Cross-Sectional Studies; Data Interpretation, Statistical; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Mianserin; Mirtazapine; Paroxetine; Patient Dropouts; Placebo Effect; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Research Design; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |
[The transfer of selective serotonin reuptake inhibitors to human milk].
Topics: Antidepressive Agents; Breast Feeding; Citalopram; Depression, Postpartum; Female; Fluoxetine; Fluvoxamine; Humans; Infant; Infant, Newborn; Milk, Human; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth muscle.
Topics: Animals; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Selective Serotonin Reuptake Inhibitors | 2001 |
Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.
Topics: Animals; Binding, Competitive; Brain; Carrier Proteins; Citalopram; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Fluoxetine; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism; Structure-Activity Relationship; Symporters | 2001 |
Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma by temperature-programmed packed capillary liquid chromatography with on-column focusing of large injection volumes.
Topics: Chromatography, Liquid; Citalopram; Fluoxetine; Humans; Paroxetine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2002 |
Reduced serotonin release and serotonin uptake sites in the rat nucleus accumbens and striatum after prenatal cocaine exposure.
Topics: Animals; Animals, Newborn; Citalopram; Cocaine; Cocaine-Related Disorders; Electric Stimulation; Female; Fenfluramine; Fetus; Fluoxetine; Methiothepin; Neostriatum; Nucleus Accumbens; p-Chloroamphetamine; Potassium; Pregnancy; Prenatal Exposure Delayed Effects; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents | 2002 |
Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents.
Topics: Animals; Calcium Channels, L-Type; Cation Transport Proteins; Citalopram; Ether-A-Go-Go Potassium Channels; Fluoxetine; Guinea Pigs; Heart Ventricles; Long QT Syndrome; Male; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Selective Serotonin Reuptake Inhibitors | 2002 |
Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 2: 4-substituted 6-nitroquipazines.
Topics: Animals; Binding, Competitive; Carrier Proteins; Cerebral Cortex; Citalopram; Drug Design; Fluoxetine; Inhibitory Concentration 50; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Models, Structural; Nerve Tissue Proteins; Paroxetine; Quipazine; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship | 2002 |
5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors.
Topics: Apoptosis; Biopsy; Blotting, Western; Burkitt Lymphoma; Carrier Proteins; Caspases; Cell Survival; Citalopram; DNA Damage; DNA, Neoplasm; Fluoxetine; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tumor Cells, Cultured | 2002 |
Potentiation of DOM-induced stimulus control by fluoxetine and citalopram: role of pharmacokinetics.
Topics: Animals; Brain; Citalopram; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Fluoxetine; Gas Chromatography-Mass Spectrometry; Hallucinogens; Male; Rats; Rats, Inbred F344; Reinforcement, Psychology; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 2002 |
Impaired spatial learning in the Morris water maze induced by serotonin reuptake inhibitors in rats.
Topics: Animals; Citalopram; Discrimination, Psychological; Dose-Response Relationship, Drug; Fluoxetine; Male; Maze Learning; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2002 |
Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta.
Topics: Citalopram; Female; Fluoxetine; Humans; Maternal-Fetal Exchange; Placenta; Pregnancy; Prospective Studies; Protein Binding; Selective Serotonin Reuptake Inhibitors | 2002 |
The effects of acute and subchronic treatment with fluoxetine and citalopram on stimulus control by DOM.
Topics: Animals; Behavior, Animal; Citalopram; Conditioning, Operant; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Male; Rats; Rats, Inbred F344; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Stimulation, Chemical; Time Factors | 2002 |
Effect of YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT 2A receptor antagonistic activity, on a marble-burying behavior test as an obsessive-compulsive disorder model.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine; Injections, Intraperitoneal; Male; Mice; Mice, Inbred ICR; Morpholines; Motor Activity; Obsessive-Compulsive Disorder; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors | 2002 |
Antidepressant effects on kinase gene expression patterns in rat brain.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Citalopram; Fluoxetine; Gene Expression Regulation; Male; Oligonucleotide Array Sequence Analysis; Phosphotransferases; Rats; RNA, Messenger; Time Factors | 2002 |
[11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.
Topics: Adrenergic Uptake Inhibitors; Animals; Benzylamines; Brain; Carrier Proteins; Cats; Citalopram; Dopamine Antagonists; Fluoxetine; Haloperidol; Maprotiline; Membrane Glycoproteins; Membrane Transport Proteins; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time Factors; Tissue Distribution; Tomography, Emission-Computed; Tranylcypromine | 2003 |
Positron emission tomography imaging of the serotonin transporter in the pig brain using [11C](+)-McN5652 and S-([18F]fluoromethyl)-(+)-McN5652.
Topics: Animals; Binding Sites; Brain; Carbon Radioisotopes; Carrier Proteins; Citalopram; Female; Fluorine Radioisotopes; Fluoxetine; Isoquinolines; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Radioactive Tracers; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Swine; Tissue Distribution; Tomography, Emission-Computed | 2003 |
Simultaneous quantification of citalopram, clozapine, fluoxetine, norfluoxetine, maprotiline, desmethylmaprotiline and trazodone in human serum by HPLC analysis.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Chromatography, High Pressure Liquid; Citalopram; Clozapine; Fluoxetine; Humans; Maprotiline; Trazodone | 2002 |
Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells.
Topics: Apoptosis; B-Lymphocytes; Burkitt Lymphoma; Calcium Signaling; Carrier Proteins; Citalopram; Fluoxetine; Gene Expression Regulation; Genes, bcl-2; Genes, myc; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Monocytes; Monomeric GTP-Binding Proteins; Neoplasm Proteins; Neoplastic Stem Cells; Nerve Tissue Proteins; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Paroxetine; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Transcription Factors | 2003 |
Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center.
Topics: Citalopram; Clinical Pharmacy Information Systems; Cost Control; Cost Savings; Drug Administration Schedule; Drug Costs; Drug Utilization; Fluoxetine; Fluvoxamine; Hospital Costs; Hospitals, Veterans; Humans; Mental Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2003 |
[Clinical significance of adrenoreactivity in patients with some paroxysmal disorders (panic attacks and migraine)].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Citalopram; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Humans; Hypertension; Male; Metoprolol; Migraine Disorders; Panic Disorder; Parasympathetic Nervous System; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Sympathetic Nervous System | 2003 |
Burning mouth syndrome as a side effect of SSRIs.
Topics: Burning Mouth Syndrome; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2003 |
Placental passage of antidepressant medications.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fetal Blood; Fluoxetine; Humans; Maternal-Fetal Exchange; Paroxetine; Placenta; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Sertraline | 2003 |
The effect of combined administration of ethanol and sertraline, fluoxetine and citalopram on rabbit EEG.
Topics: Analysis of Variance; Animals; Brain; Citalopram; Electroencephalography; Ethanol; Female; Fluoxetine; Male; Rabbits; Sertraline | 2003 |
Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension.
Topics: Analysis of Variance; Animals; Carrier Proteins; Chronic Disease; Citalopram; Disease Models, Animal; Fluoxetine; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Ketanserin; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Muscle, Smooth, Vascular; Nerve Tissue Proteins; Oxadiazoles; Piperazines; Pulmonary Artery; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Statistics, Nonparametric | 2003 |
Differential neurochemical properties of central serotonergic transmission in Roman high- and low-avoidance rats.
Topics: Animals; Anxiety; Autoradiography; Avoidance Learning; Behavior, Animal; Binding, Competitive; Brain; Central Nervous System; Citalopram; Clomipramine; Depression; Fluoxetine; Male; Microdialysis; Rats; Rats, Inbred Strains; Selective Serotonin Reuptake Inhibitors; Serotonin; Species Specificity; Synaptic Transmission; Tritium | 2003 |
Functional coupling of serotonin and noradrenaline transporters.
Topics: Amino Acid Sequence; Animals; Antidepressive Agents; Binding, Competitive; Carrier Proteins; Cell Line; Cell Membrane; Citalopram; Fluoxetine; Humans; Imipramine; Immunoblotting; Kidney; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Sequence Data; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Recombinant Fusion Proteins; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters; Transfection; Tritium | 2003 |
Paradoxical effects of opioid antagonist naloxone on SSRI-induced analgesia and tolerance in mice.
Topics: Analgesics; Animals; Citalopram; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Tolerance; Fluoxetine; Injections, Intraperitoneal; Injections, Spinal; Mice; Naloxone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors | 2003 |
Selective serotonin reuptake inhibitors in pilot fatalities of civil aviation accidents, 1990-2001.
Topics: Accidents, Aviation; Aerospace Medicine; Certification; Citalopram; Databases as Topic; Environmental Monitoring; Fluoxetine; Humans; Paroxetine; Postmortem Changes; Selective Serotonin Reuptake Inhibitors; Sertraline; Survival Rate; United States | 2003 |
Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects.
Topics: 5,7-Dihydroxytryptamine; Animals; Behavior, Animal; Biogenic Monoamines; Brain; Brain Chemistry; Chromatography, High Pressure Liquid; Citalopram; Cocaine; Conditioning, Operant; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Sertraline; Tissue Distribution | 2004 |
5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy.
Topics: Action Potentials; Aminopyridines; Animals; Citalopram; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Electromyography; Epilepsy, Absence; Fluoxetine; Indoles; Injections, Intraperitoneal; Injections, Intraventricular; Male; Piperazines; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Doxepin; Drug Overdose; Drug Prescriptions; Emergency Service, Hospital; Female; Fluoxetine; Humans; Imipramine; Information Services; Male; Mianserin; Mirtazapine; Paroxetine; Patient Admission; Patient Readmission; Poison Control Centers; Retrospective Studies; Risk Assessment; Scotland; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Trazodone; Venlafaxine Hydrochloride | 2004 |
Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
Topics: Adult; Benzylamines; Carbon Radioisotopes; Carrier Proteins; Citalopram; Corpus Striatum; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tomography, Emission-Computed; Venlafaxine Hydrochloride | 2004 |
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
Topics: Animals; Antidepressive Agents; Citalopram; Depression; Desipramine; Dopamine beta-Hydroxylase; Droxidopa; Fluoxetine; Gene Deletion; Mice; Morpholines; Norepinephrine; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Tail | 2004 |
The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.
Topics: Animals; Autoreceptors; Cerebral Cortex; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Guinea Pigs; Hypothalamus; Indoles; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Piperidines; Piperidones; Pyrimidines; Rats; Rats, Inbred Strains; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Presynaptic; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Species Specificity; Spiro Compounds; Subcellular Fractions; Triazoles; Tritium; United Kingdom | 2004 |
Changes in energy after switching from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine.
Topics: Citalopram; Depressive Disorder; Drug Administration Schedule; Fatigue; Fluoxetine; Humans; Paroxetine; Quality of Life; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Neonatal complications after intrauterine exposure to SSRI antidepressants.
Topics: Antidepressive Agents; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; France; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
[The peculiarities of panic disorders determined by gender dimorphism].
Topics: Antidepressive Agents, Second-Generation; Beta Rhythm; Citalopram; Electroencephalography; Female; Fluoxetine; Humans; Male; Panic Disorder; Phobic Disorders; Psychometrics; Selective Serotonin Reuptake Inhibitors; Sex Factors; Time Factors | 2004 |
Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety.
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Bupropion; Citalopram; Cyclohexanols; Depression; Drug Therapy; Fluoxetine; Humans; Paroxetine; Patient Satisfaction; Primary Health Care; Psychiatry; Psychology; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Work | 2004 |
Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia.
Topics: Animals; Citalopram; Cladocera; Ecosystem; Female; Fluoxetine; Fluvoxamine; Lethal Dose 50; Male; No-Observed-Adverse-Effect Level; Paroxetine; Reproduction; Selective Serotonin Reuptake Inhibitors; Sertraline; Toxicity Tests, Acute; Toxicity Tests, Chronic; Water Pollutants, Chemical | 2004 |
Selective serotonin reuptake inhibitors induce spontaneous interneuronal activity in the leech nervous system.
Topics: Action Potentials; Adrenergic Uptake Inhibitors; Animals; Citalopram; Drug Interactions; Electric Stimulation; Fluoxetine; Ganglia, Invertebrate; Imipramine; In Vitro Techniques; Interneurons; Leeches; Membrane Potentials; Neural Networks, Computer; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Synapses | 2005 |
Specific in vitro binding of (S,S)-[3H]MeNER to norepinephrine transporters.
Topics: Animals; Autoradiography; Brain; Citalopram; Competitive Bidding; Dose-Response Relationship, Drug; Fluoxetine; In Vitro Techniques; Mice; Mice, Knockout; Norepinephrine Plasma Membrane Transport Proteins; Phenols; Piperazines; Protein Binding; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Symporters; Tissue Distribution | 2005 |
Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
Topics: Amphetamines; Animals; Choroid Plexus; Citalopram; Dose-Response Relationship, Drug; Ergolines; Fluoxetine; Hydrolysis; Inositol Phosphates; Male; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Second Messenger Systems; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2005 |
Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine.
Topics: Animals; Animals, Newborn; Behavior, Animal; Citalopram; Clomipramine; Female; Fluoxetine; Maternal-Fetal Exchange; Morphine Dependence; Naloxone; Narcotic Antagonists; Pregnancy; Pregnancy Complications; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 2005 |
Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).
Topics: Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Citalopram; Cyclohexanols; Depression; Female; Fluoxetine; Humans; Male; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Venlafaxine Hydrochloride | 2005 |
Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Child; Citalopram; Cohort Studies; Cyclohexanols; Databases, Factual; Female; Fluoxetine; Hospitalization; Humans; Male; Middle Aged; Prevalence; Risk Factors; Sex Factors; Suicide, Attempted; Time Factors; United Kingdom; Venlafaxine Hydrochloride | 2005 |
Depression in general clinical practice.
Topics: Age Factors; Aged; Antidepressive Agents; Citalopram; Depression; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Risk Factors; Treatment Outcome | 2004 |
Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation.
Topics: Adult; Citalopram; Depression; Female; Fluoxetine; Humans; Male; Middle Aged; Netherlands; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors | 2005 |
Causal or casual?
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Drug Overdose; Fluoxetine; Humans; Risk Factors; Suicide, Attempted; Venlafaxine Hydrochloride | 2005 |
Interpersonal psychotherapy for depression with panic spectrum symptoms: a pilot study.
Topics: Anxiety Disorders; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Interpersonal Relations; Male; Panic Disorder; Paroxetine; Pilot Projects; Problem Solving; Psychotherapy; Quality of Life; Selective Serotonin Reuptake Inhibitors | 2005 |
Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Mirtazapine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Solid Phase Microextraction; Venlafaxine Hydrochloride | 2005 |
Serotonin modulates circadian entrainment in Drosophila.
Topics: 5-Hydroxytryptophan; Animals; Animals, Genetically Modified; Brain Chemistry; Circadian Rhythm; Citalopram; Drosophila; Fluoxetine; Glycogen Synthase Kinase 3; Immunohistochemistry; Light; Mutation; Phosphorylation; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; RNA Interference; Selective Serotonin Reuptake Inhibitors; Serotonin | 2005 |
Quinolinic acid toxicity on orexin neurons blocked by gamma aminobutyric acid type A receptor stimulation.
Topics: Animals; Animals, Newborn; Bicuculline; Cell Count; Citalopram; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Hypothalamus; Immunohistochemistry; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Magnesium; Neurons; Neuropeptides; Nipecotic Acids; Norepinephrine; Orexin Receptors; Orexins; Organophosphorus Compounds; Picrotoxin; Quinolinic Acid; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, GABA-A; Receptors, Neuropeptide; Selective Serotonin Reuptake Inhibitors; Serotonin | 2005 |
N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.
Topics: Amines; Benztropine; Binding Sites; Citalopram; Cocaine; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; Kinetics; Ligands; Models, Molecular; Molecular Conformation; Muscarinic Antagonists; Parasympatholytics; Pirenzepine | 2005 |
Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats.
Topics: Administration, Oral; Animals; Antidepressive Agents; Body Temperature; Circadian Rhythm; Citalopram; Cross-Over Studies; Desipramine; Electroencephalography; Electromyography; Fluoxetine; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Sleep, REM; Species Specificity | 2005 |
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.
Topics: Adrenergic Uptake Inhibitors; Amino Acid Sequence; Animals; Antidepressive Agents; Binding Sites; Binding, Competitive; Blotting, Western; Cadmium; Cell Line; Cell Membrane; Citalopram; Clomipramine; Cocaine; Cysteine; Dopamine Uptake Inhibitors; Fluoxetine; HeLa Cells; Humans; Immunoprecipitation; Isoleucine; Kinetics; LLC-PK1 Cells; Mazindol; Methionine; Mice; Models, Chemical; Molecular Sequence Data; Mutation; N-Methyl-3,4-methylenedioxyamphetamine; Nomifensine; Protein Binding; Protein Structure, Tertiary; Protein Transport; Radiopharmaceuticals; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Species Specificity; Stereoisomerism; Substrate Specificity; Tyrosine | 2006 |
Development of a solid phase extraction for 13 'new' generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric analysis.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Desvenlafaxine Succinate; Fluoxetine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Microchemistry; Mirtazapine; Piperazines; Reproducibility of Results; Sertraline | 2005 |
Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice.
Topics: Acoustic Stimulation; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Behavior, Animal; Central Nervous System Stimulants; Citalopram; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluoxetine; Inhibition, Psychological; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Mice, Knockout; Norepinephrine Plasma Membrane Transport Proteins; Reaction Time; Reflex, Startle; Selective Serotonin Reuptake Inhibitors | 2006 |
From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram.
Topics: Analgesics; Animals; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Male; Mice; Mice, Inbred ICR; Pain Measurement; Selective Serotonin Reuptake Inhibitors | 2006 |
Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Topics: Action Potentials; Allosteric Regulation; Animals; Antidepressive Agents, Second-Generation; Brain; Chlorocebus aethiops; Citalopram; COS Cells; Drug Interactions; Fluoxetine; Hippocampus; Male; Microdialysis; Paroxetine; Protein Binding; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism; Transfection | 2007 |
Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway.
Topics: Calibration; Chemical Fractionation; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Fluvoxamine; Norway; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Sewage; Water Pollutants, Chemical | 2006 |
Persistent sexual side effects after SSRI discontinuation.
Topics: Adult; Androgens; Anxiety; Bupropion; Cabergoline; Citalopram; Depressive Disorder; Dopamine Agonists; Dopamine Uptake Inhibitors; Ergolines; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Piperazines; Plants, Medicinal; Purines; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sleep Initiation and Maintenance Disorders; Sulfones; Testosterone; Time Factors; Treatment Outcome; Vasodilator Agents | 2006 |
Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety.
Topics: Adrenergic alpha-Antagonists; Alprazolam; Animals; Anxiety; Citalopram; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Hypnotics and Sedatives; Male; Motor Activity; Panic Disorder; Paroxetine; Periaqueductal Gray; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stereotaxic Techniques; Yohimbine | 2006 |
Successful treatment of epilepsy with serotonin reuptake inhibitors: proposed mechanism.
Topics: Adolescent; Adult; Aged; Amino Acids; Citalopram; Clinical Trials as Topic; Epilepsy; Female; Fluoxetine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Tryptophan | 2006 |
Screening of citalopram, fluoxetine and their metabolites in human urine samples by gas chromatography-mass spectrometry. A global robustness/ruggedness study.
Topics: Citalopram; Fluoxetine; Gas Chromatography-Mass Spectrometry; Humans; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity | 2006 |
(-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
Topics: Animals; Benzofurans; Blood Platelets; Brain; Cell Line; Citalopram; Clorgyline; Dose-Response Relationship, Drug; Fluoxetine; Humans; Imipramine; Iproniazid; Isoenzymes; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Selegiline; Serotonin; Stilbenes; Synaptosomes; Tritium; Wine | 2006 |
Cytochrome P450 (CYP) inhibition screening: comparison of three tests.
Topics: Citalopram; Cytochrome P-450 Enzyme Inhibitors; Diazepam; Enzyme Inhibitors; Fluoxetine; Humans; Oxazepam; Propranolol; Sotalol | 2006 |
[A 74-year-old unconscious woman with myoclonia and seizures].
Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Citalopram; Female; Fluoxetine; Humans; Mianserin; Myoclonus; Olanzapine; Poisoning; Seizures; Selective Serotonin Reuptake Inhibitors; Unconsciousness | 2006 |
The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Benzylamines; Cerebral Cortex; Citalopram; Desipramine; Dopamine beta-Hydroxylase; Fluoxetine; Hindlimb Suspension; Immunohistochemistry; Locus Coeruleus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Norepinephrine; Oxidopamine; Presynaptic Terminals; Raphe Nuclei; Selective Serotonin Reuptake Inhibitors | 2007 |
Cost-utility of selective serotonin reuptake inhibitors for depression in primary care in Catalonia.
Topics: Adolescent; Adult; Aged; Catchment Area, Health; Citalopram; Cost-Benefit Analysis; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Health Expenditures; Humans; Male; Middle Aged; Paroxetine; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Spain | 2006 |
Acute and repeated administration of fluoxetine, citalopram, and paroxetine significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Topics: Action Potentials; Analysis of Variance; Animals; Citalopram; Dopamine; Drug Administration Schedule; Fluoxetine; Male; Mesencephalon; Neurons; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2007 |
Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cohort Studies; Cyclohexanols; Dothiepin; Fluoxetine; Humans; Incidence; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Suicide; Venlafaxine Hydrochloride | 2007 |
[Alopecia associated with the use of serotonin selective reuptake inhibitors: two case reports].
Topics: Alopecia; Citalopram; Female; Fluoxetine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors | 2006 |
Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Brain; Citalopram; Desipramine; Dopamine; Fenclonine; Fluoxetine; Hindlimb Suspension; Male; Mice; Mice, Inbred C57BL; Morpholines; Norepinephrine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin | 2007 |
FLUOXETINE modifies the expression of serotonergic markers in a differentiation-dependent fashion in the mesencephalic neural cell line A1 mes c-myc.
Topics: Analysis of Variance; Animals; Cell Count; Cell Differentiation; Cell Line; Citalopram; Dose-Response Relationship, Drug; Embryo, Mammalian; Fluoxetine; Gene Expression; Mesencephalon; Mice; Neurons; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time Factors; Tryptophan Hydroxylase; Vesicular Monoamine Transport Proteins | 2007 |
Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate.
Topics: Animals; Brain; Bridged Bicyclo Compounds, Heterocyclic; Citalopram; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; In Vitro Techniques; Male; Methylphenidate; Quinolizines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism; Structure-Activity Relationship | 2007 |
Simple options for improving signal detection in antidepressant clinical trials.
Topics: Antidepressive Agents; Citalopram; Clinical Trials as Topic; Databases, Factual; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Fluoxetine; Likelihood Functions; Models, Statistical; Paroxetine; Personality Inventory; Placebo Effect; Psychometrics; Reproducibility of Results; Research Design; Signal Detection, Psychological; Thiophenes; Treatment Outcome | 2007 |
Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist.
Topics: Acoustic Stimulation; Animals; Behavior, Animal; Citalopram; Conditioning, Psychological; Drug Interactions; Fear; Fluoxetine; Freezing Reaction, Cataleptic; Indoles; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Time Factors; Tropisetron | 2007 |
Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Drug Utilization Review; Female; Fluoxetine; Humans; Hyperprolactinemia; Italy; Male; Medical Records; Mental Disorders; Olanzapine; Paroxetine; Practice Patterns, Physicians'; Retrospective Studies; Risperidone; Sertraline; Treatment Outcome | 2008 |
Serotonergic mechanisms in human allergic contact dermatitis.
Topics: Amphetamines; Blood Platelets; Cell Line; Cell Proliferation; Citalopram; Dermatitis, Allergic Contact; Fluoxetine; Humans; Immunohistochemistry; Interleukin-1beta; Interleukin-2; Irritants; Leukocytes, Mononuclear; Nickel; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists | 2007 |
Effects of citalopram and fluoxetine on the corticocerebral blood flow in conscious rabbits.
Topics: Animals; Antidepressive Agents, Second-Generation; Blood Pressure; Brain Ischemia; Carotid Arteries; Cerebral Cortex; Cerebrovascular Circulation; Citalopram; Consciousness; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Fluoxetine; Heart Rate; Ligation; Rabbits; Selective Serotonin Reuptake Inhibitors | 2007 |
Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.
Topics: Aged; Aged, 80 and over; Algorithms; Bayes Theorem; Citalopram; Cost-Benefit Analysis; Depression; Drugs, Generic; Female; Fluoxetine; Humans; Male; Medicare; Models, Statistical; Paroxetine; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States | 2007 |
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Effects of serotonergic anxiolytics on the freezing behavior in the elevated open-platform test in mice.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Citalopram; Dose-Response Relationship, Drug; Fear; Fluoxetine; Male; Mice; Mice, Inbred ICR; Motor Activity; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin | 2007 |
Regulation of the human serotonin transporter mediated by long-term action of serotonin in Caco-2 cells.
Topics: Caco-2 Cells; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; Gene Expression Regulation; Humans; Receptors, Serotonin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2008 |
Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression.
Topics: Adolescent; Age Factors; Animals; Antidepressive Agents; Child; Citalopram; Depressive Disorder; Desipramine; Disease Models, Animal; Escape Reaction; Fluoxetine; Helplessness, Learned; Humans; Imipramine; Injections, Intraperitoneal; Male; Motivation; Rats; Rats, Sprague-Dawley; Swimming; Tranylcypromine | 2008 |
Simultaneous determination of citalopram, fluoxetine and their main metabolites in human urine samples by solid-phase microextraction coupled with high-performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Humans; Hydrogen-Ion Concentration; Osmolar Concentration; Solid Phase Extraction; Temperature | 2008 |
Monoaminergic compensation in the neuropeptide Y deficient mouse brain.
Topics: Animals; Autoradiography; Biogenic Monoamines; Brain Chemistry; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Immunohistochemistry; Male; Mice; Mice, Knockout; Neuropeptide Y; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tyrosine 3-Monooxygenase | 2008 |
Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents; Behavior, Animal; Choice Behavior; Citalopram; Corticosterone; Depressive Disorder; Disease Models, Animal; Fluoxetine; Food Preferences; Hypothermia; Maze Learning; Mice; Mice, Knockout; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sleep Wake Disorders; Spectrum Analysis; Stress, Physiological; Wakefulness | 2008 |
Glucocorticoid receptor antagonism augments fluoxetine-induced downregulation of the 5-HT transporter.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Autoradiography; Brain; Citalopram; Densitometry; Down-Regulation; Fluoxetine; In Situ Hybridization; Male; Rats; Receptor, Serotonin, 5-HT1A; Receptors, Glucocorticoid; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Serotonin Plasma Membrane Transport Proteins; Steroids; Sulfones; Tritium; Tryptophan Hydroxylase | 2009 |
Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Body Temperature; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; Genotype; Hindlimb Suspension; Hippocampus; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Microdialysis; Motor Activity; Norepinephrine Plasma Membrane Transport Proteins; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Species Specificity; Tyrosine 3-Monooxygenase | 2008 |
Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole augment the effects of antidepressants acting via serotonergic system in the forced swimming test in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Citalopram; Drug Interactions; Enzyme Inhibitors; Fluoxetine; Imidazoles; Male; Morpholines; Motor Activity; Nitric Oxide Synthase Type I; Rats; Rats, Wistar; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming; Thiazepines | 2008 |
Plasminogen activator inhibitor-1 gene is associated with major depression and antidepressant treatment response.
Topics: Adult; Antidepressive Agents; Case-Control Studies; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Pharmacogenetics; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2008 |
Platelet serotonin uptake in drug-naïve depressive patients before and after treatment with citalopram.
Topics: Adult; Blood Platelets; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Serotonin; Severity of Illness Index; Sex Factors | 2008 |
Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Brain; Citalopram; Cricetinae; Dopamine; Drug Synergism; Fluoxetine; Gerbillinae; Isoindoles; Male; Mesocricetus; Mice; Neurokinin-1 Receptor Antagonists; Neurons; Norepinephrine; Piperidines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Tetrazoles | 2009 |
The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: a pharmacoeconomic evaluation.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Decision Support Techniques; Depressive Disorder, Major; Economics, Pharmaceutical; Fluoxetine; Focus Groups; Humans; Models, Theoretical; Psychometrics; Selective Serotonin Reuptake Inhibitors; Thailand; Venlafaxine Hydrochloride | 2008 |
Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response.
Topics: Citalopram; Depression; DNA; Fluoxetine; Haplotypes; Humans; Monoamine Oxidase; Pharmacogenetics; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Sequence Tagged Sites; Serotonin; Tryptophan Hydroxylase | 2009 |
The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Aspartic Acid; Citalopram; Fenclonine; Fluoxetine; Male; Mice; Morpholines; Motor Activity; Organometallic Compounds; Piperazines; Pyridines; Rats; Rats, Wistar; Reboxetine; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Antagonists; Swimming; Zinc Compounds | 2009 |
Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes.
Topics: Adult; Birth Weight; Case-Control Studies; Citalopram; Female; Fetal Blood; Fetal Development; Fetal Growth Retardation; Fetus; Fluoxetine; Hormones; Humans; Hypothalamo-Hypophyseal System; Infant, Newborn; Insulin-Like Growth Factor I; Male; Paroxetine; Pituitary-Adrenal System; Placenta; Pregnancy; Selective Serotonin Reuptake Inhibitors | 2009 |
Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Selective Serotonin Reuptake Inhibitors; Taiwan; Tryptophan Hydroxylase | 2009 |
Lack of CB1 receptor activity impairs serotonergic negative feedback.
Topics: Animals; Area Under Curve; Citalopram; Dose-Response Relationship, Drug; Extracellular Fluid; Feedback, Physiological; Fluoxetine; Gene Expression; Hippocampus; Male; Mice; Mice, Knockout; Microdialysis; Neurons; Prefrontal Cortex; Protein Binding; Raphe Nuclei; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tritium | 2009 |
The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression.
Topics: Antidepressive Agents, Second-Generation; Case-Control Studies; Chromatography, High Pressure Liquid; Citalopram; Depression; Female; Fluoxetine; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans | 2009 |
Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Databases as Topic; Depression; Drug Costs; Drug Prescriptions; Drugs, Generic; Female; Fluoxetine; Humans; Insurance, Pharmaceutical Services; Likelihood Functions; Logistic Models; Male; Medication Adherence; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Time Factors; United States | 2009 |
Fast separation of selective serotonin reuptake inhibitors antidepressants in plasma sample by nonaqueous capillary electrophoresis.
Topics: Antidepressive Agents; Citalopram; Drug Monitoring; Electrophoresis, Capillary; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors.
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Citalopram; Cognition; Cognition Disorders; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Movement Disorders; Neuropsychological Tests; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index | 2010 |
5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.
Topics: Adolescent; Adult; Aged; Citalopram; Depressive Disorder, Major; Fluoxetine; Humans; Middle Aged; Paroxetine; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Tryptophan Hydroxylase; Young Adult | 2009 |
Depletion of selective serotonin reuptake inhibitors during sewage sludge composting.
Topics: Bacteria, Aerobic; Biodegradation, Environmental; Bioreactors; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sewage; Soil Pollutants; Waste Disposal, Fluid | 2009 |
Development of a stir bar sorptive extraction based HPLC-FLD method for the quantification of serotonin reuptake inhibitors in plasma, urine and brain tissue samples.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Chromatography, High Pressure Liquid; Citalopram; Cyclohexanols; Fluorescence; Fluoxetine; Humans; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2010 |
SSRI antidepressants do not confound single photon emission computed tomography (SPECT) imaging studies using the alpha4beta2 nicotinic acetylcholine receptor [123I]5-I-A85380 ligand: in vivo and in vitro evidence.
Topics: Adult; Antidepressive Agents, Second-Generation; Autoradiography; Azetidines; Brain; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Pyridines; Receptors, Nicotinic; Selective Serotonin Reuptake Inhibitors; Time Factors; Tomography, Emission-Computed, Single-Photon | 2010 |
The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
Topics: Adolescent; Antidepressive Agents; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Female; Fluoxetine; Humans; Male; Multicenter Studies as Topic; Paroxetine; Personality Assessment; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide Prevention; Suicide, Attempted; Venlafaxine Hydrochloride | 2009 |
Acute SSRI-induced anxiogenic and brain metabolic effects are attenuated 6 months after initial MDMA-induced depletion.
Topics: Animals; Anxiety; Axons; Brain; Citalopram; Fluoxetine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neuropsychological Tests; Piperazines; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Social Behavior; Time Factors | 2010 |
Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: kappa opioid and serotonergic mechanisms.
Topics: Animals; Benzofurans; Citalopram; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Fluoxetine; Ligands; Naltrexone; Pyrrolidines; Receptors, Opioid, kappa; Saimiri; Selective Serotonin Reuptake Inhibitors; Self Administration; Serotonin; Serotonin 5-HT1 Receptor Agonists | 2010 |
Changes in antidepressant metabolism in pregnancy evidenced by metabolic ratios in hair: a novel approach.
Topics: Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Female; Fluoxetine; Gas Chromatography-Mass Spectrometry; Hair; Humans; Postpartum Period; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Third; Sertraline; Venlafaxine Hydrochloride | 2010 |
A common mechanism of action of the selective serotonin reuptake inhibitors citalopram and fluoxetine: reversal of chronic psychosocial stress-induced increase in CRE/CREB-directed gene transcription in transgenic reporter gene mice.
Topics: Animals; Brain; Citalopram; Cyclic AMP Response Element-Binding Protein; Drug Administration Schedule; Fluoxetine; Gene Expression Regulation; Genes, Reporter; Mice; Mice, Transgenic; Phosphorylation; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Transcription, Genetic | 2010 |
Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cells, Cultured; Citalopram; Cytokines; Disease Models, Animal; Disease Progression; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Fluoxetine; Humans; Macrophages; Male; Mice; Mice, Inbred DBA; Selective Serotonin Reuptake Inhibitors; Synovial Membrane; Toll-Like Receptors | 2010 |
Deaths involving serotonergic drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Australia; Cause of Death; Citalopram; Cyclohexanols; Female; Fluoxetine; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Serotonin Agents; Sertraline; Tramadol; Venlafaxine Hydrochloride | 2010 |
Melatonin inhibits serotonin transporter activity in intestinal epithelial cells.
Topics: Analysis of Variance; Caco-2 Cells; Citalopram; Fluoxetine; Humans; Intestinal Mucosa; Melatonin; Receptors, Melatonin; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2010 |
Use of antidepressants in children: is it time for a comparative effectiveness trial?
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Male; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Cohort Studies; Cross-Sectional Studies; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide; Suicide Prevention; Suicide, Attempted | 2010 |
Potential role of glutamate neurotransmission in the pathogenesis of ischemic brain damage and of depression. Effects of L-kynurenine on the survival of the hippocampal neurons and on the corticocerebral blood flow in ischemic animal models.
Topics: Animals; Brain Ischemia; Cell Survival; Cerebrovascular Circulation; Chromatography, High Pressure Liquid; Citalopram; Depression; Disease Models, Animal; Electrophysiology; Fluoxetine; Glutamic Acid; Hippocampus; Kynurenine; Male; Rabbits; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Synaptic Transmission; Wakefulness | 2010 |
Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.
Topics: Adult; Aged; Antidepressive Agents; British Columbia; Cause of Death; Citalopram; Cohort Studies; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Hospitalization; Humans; Male; Middle Aged; Paroxetine; Proportional Hazards Models; Risk; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide, Attempted | 2010 |
An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Comorbidity; Cyclohexanols; Depressive Disorder; England; Fluoxetine; Guideline Adherence; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Practice Patterns, Physicians'; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants.
Topics: Animals; Antidepressive Agents; Attention; Behavior, Animal; Citalopram; Cognition Disorders; Desipramine; Drug Administration Schedule; Fluoxetine; Male; Nomifensine; Rats; Rats, Sprague-Dawley; Stress, Psychological; Time Factors | 2011 |
Antidepressants act on glial cells: SSRIs and serotonin elicit astrocyte calcium signaling in the mouse prefrontal cortex.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Aniline Compounds; Animals; Animals, Newborn; Astrocytes; Calcium Signaling; Citalopram; Drug Interactions; Excitatory Amino Acid Antagonists; Fluoxetine; Glutamic Acid; In Vitro Techniques; Mice; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Serotonin; Sodium Channel Blockers; Tetrodotoxin; Xanthenes | 2011 |
What one hand giveth the other taketh away: some unpredicted effects of enantiomers in psychopharmacology.
Topics: Animals; Azabicyclo Compounds; Citalopram; Eszopiclone; Fluoxetine; Humans; Mental Disorders; Molecular Structure; Piperazines; Psychotropic Drugs; Rats; Selective Serotonin Reuptake Inhibitors; Stereoisomerism | 2010 |
The effects of antidepressants on the results of skin prick tests used in the diagnosis of allergic diseases.
Topics: Adult; Allergens; Antidepressive Agents; Citalopram; False Negative Reactions; Female; Fluoxetine; Histamine; Humans; Hypersensitivity; Male; Middle Aged; Skin Tests; Young Adult | 2011 |
Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.
Topics: Action Potentials; Animals; Antidepressive Agents; Autoreceptors; Brain; Calcium; Citalopram; Extracellular Space; Fluoxetine; Hydroxyindoleacetic Acid; Organ Culture Techniques; Paroxetine; Raphe Nuclei; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time Factors; Tryptophan Hydroxylase | 2010 |
Selective serotonin reuptake inhibitor antidepressants potentiate methylphenidate (Ritalin)-induced gene regulation in the adolescent striatum.
Topics: Analysis of Variance; Animals; Autoradiography; Citalopram; Corpus Striatum; Dopamine Uptake Inhibitors; Early Growth Response Protein 1; Fluoxetine; Gene Expression; In Situ Hybridization; Male; Methylphenidate; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Selective Serotonin Reuptake Inhibitors | 2010 |
Effects of selective serotonin reuptake inhibitors on GABAergic inhibition in the hippocampus of normal and pilocarpine induced epileptic rats.
Topics: Analysis of Variance; Animals; Citalopram; Electroencephalography; Epilepsy; Fluoxetine; gamma-Aminobutyric Acid; Hippocampus; Male; Neural Inhibition; Neurons; Paroxetine; Pilocarpine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Vesicular Inhibitory Amino Acid Transport Proteins | 2010 |
Role of serotonin transporter inhibition in the regulation of tryptophan hydroxylase in brainstem raphe nuclei: time course and regional specificity.
Topics: Animals; Citalopram; Fluoxetine; Immunohistochemistry; Male; Organ Specificity; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Time Factors; Tryptophan Hydroxylase | 2010 |
Environmental risk assessment of three selective serotonin reuptake inhibitors in the aquatic environment: a case study including a cocktail scenario.
Topics: Biodegradation, Environmental; Citalopram; Environmental Monitoring; Fluoxetine; Fresh Water; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Sewage; Waste Disposal, Fluid; Water Pollutants, Chemical | 2011 |
Daily emotional dynamics in depressed youth: a cell phone ecological momentary assessment study.
Topics: Adolescent; Affect; Age Factors; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cell Phone; Child; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder, Major; Female; Fluoxetine; Humans; Longitudinal Studies; Male; Personality Assessment; Puberty; Reference Values; Social Environment | 2011 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Citalopram; Corticosterone; Diazepam; Drug Interactions; Fluoxetine; Male; Mice; Mice, Inbred BALB C; Selective Serotonin Reuptake Inhibitors | 2011 |
Female sexual dysfunction in patients treated with antidepressant-comparison between escitalopram and fluoxetine.
Topics: Adult; Citalopram; Cross-Sectional Studies; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Interview, Psychological; Prevalence; Psychiatric Status Rating Scales; Psychological Tests; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2012 |
Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans.
Topics: Animals; Annexin A2; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Citalopram; Cytokines; Depressive Disorder; Drug Interactions; Fluoxetine; Humans; Male; Mice; Mice, Inbred C57BL; S100 Proteins; Selective Serotonin Reuptake Inhibitors | 2011 |
Antidepressant use during pregnancy. FPIN’s clinical inquiries.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Evidence-Based Medicine; Female; Fluoxetine; Humans; Odds Ratio; Paroxetine; Physicians, Family; Pregnancy; Pregnancy Complications; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2011 |
The antidepressant fluoxetine but not citalopram suppresses synapse formation and synaptic transmission between Lymnaea neurons by perturbing presynaptic and postsynaptic machinery.
Topics: Animals; Antidepressive Agents; Biomarkers; Calcium; Cells, Cultured; Citalopram; Fluoxetine; Humans; Lymnaea; Neuronal Plasticity; Neurons; Patch-Clamp Techniques; Selective Serotonin Reuptake Inhibitors; Synapses; Synaptic Transmission; Synaptophysin | 2011 |
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Agents; Aspirin; Canada; Citalopram; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Heart Failure; Hemorrhage; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Neoplasms; Paroxetine; Peptic Ulcer; Platelet Aggregation Inhibitors; Renal Insufficiency; Retrospective Studies; Risk; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Ticlopidine | 2011 |
The MMPI-2 neurotic triad subscales and depression levels after pharmacological treatment in patients with depressive disorders - clinical study.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Hypochondriasis; Hysteria; Male; Middle Aged; MMPI; Neurotic Disorders; Observer Variation; Paroxetine; Psychometrics; Reproducibility of Results; Sertraline; Statistics as Topic; Young Adult | 2011 |
The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Antidepressive Agents; Citalopram; Confusion; Diuretics; Drug Interactions; Female; Fibrinolytic Agents; Fluoxetine; France; Hemorrhage; Humans; Hyponatremia; Male; Pharmacovigilance; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors | 2012 |
Hypoactive sexual desire among depressed female patients treated with selective serotonin reuptake inhibitors: a comparison between escitalopram and fluoxetine.
Topics: Adolescent; Adult; Aged; Citalopram; Cross-Sectional Studies; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Interview, Psychological; Malaysia; Middle Aged; Multivariate Analysis; Prevalence; Psychiatric Status Rating Scales; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Sexual Dysfunctions, Psychological; Sexuality; Young Adult | 2012 |
Reversal of SSRI-associated apathy syndrome by discontinuation of therapy.
Topics: Aged; Antidepressive Agents; Apathy; Citalopram; Depressive Disorder; Fluoxetine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Syndrome | 2012 |
Comparison of two extraction methods for the determination of selective serotonin reuptake inhibitors in sewage sludge by hollow fiber liquid-phase microextraction.
Topics: Chromatography, Liquid; Citalopram; Fluoxetine; Liquid Phase Microextraction; Mass Spectrometry; Paroxetine; Porosity; Selective Serotonin Reuptake Inhibitors; Sertraline; Sewage; Surface Properties | 2012 |
Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats.
Topics: Animals; Antiparkinson Agents; Apomorphine; Biogenic Monoamines; Citalopram; Corpus Striatum; Dyskinesia, Drug-Induced; Fluoxetine; Levodopa; Male; Parkinsonian Disorders; Paroxetine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2012 |
Arrays of SnO2 nanorods as novel solid phase microextraction for trace analysis of antidepressant drugs in body fluids.
Topics: Antidepressive Agents, Second-Generation; Body Fluids; Calibration; Chromatography, High Pressure Liquid; Citalopram; Drug Monitoring; Fluoxetine; Humans; Hydrogen-Ion Concentration; Linear Models; Nanotubes; Osmolar Concentration; Reference Standards; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sodium Chloride; Sodium Hydroxide; Solid Phase Microextraction; Surface Properties; Time Factors; Tin Compounds | 2012 |
Sexual arousal difficulties in women treated with antidepressants: a comparison between escitalopram and fluoxetine.
Topics: Adult; Antidepressive Agents; Citalopram; Cross-Sectional Studies; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Malaysia; Middle Aged; Sexual Dysfunctions, Psychological; Surveys and Questionnaires | 2012 |
Fluoxetine suppresses synaptically induced [Ca²⁺]i spikes and excitotoxicity in cultured rat hippocampal neurons.
Topics: Animals; Calcium Channel Blockers; Calcium Signaling; Cell Death; Cells, Cultured; Citalopram; Excitatory Amino Acid Agonists; Exocytosis; Female; Fluoxetine; Hippocampus; Magnesium Deficiency; Neurons; Neuroprotective Agents; Neurotransmitter Agents; p-Chloroamphetamine; Paroxetine; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Synapses | 2013 |
Effect of fluoxetine and adenosine receptor NECA agonist on G alpha q/11 protein of C6 glioma cells.
Topics: Adenosine-5'-(N-ethylcarboxamide); Animals; Brain Neoplasms; Cell Line, Tumor; Citalopram; Depression; Fluoxetine; Glioma; GTP-Binding Protein alpha Subunits, Gq-G11; Neurons; Purinergic P1 Receptor Agonists; Rats; Selective Serotonin Reuptake Inhibitors; Sertraline; Signal Transduction | 2012 |
The pro-inflammatory cytokine TNF-α regulates the activity and expression of the serotonin transporter (SERT) in astrocytes.
Topics: Astrocytes; Cell Line, Tumor; Citalopram; Fluoxetine; Glioma; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Paroxetine; Pyridines; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tumor Necrosis Factor-alpha | 2013 |
A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline.
Topics: Acetamides; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder; Depressive Disorder, Major; Female; Fluoxetine; Humans; Hypnotics and Sedatives; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome; Young Adult | 2013 |
The pharmacoepidemiology of selective serotonin reuptake inhibitors for children and adolescents in Canada from 2005 to 2009: a database analysis.
Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents; Canada; Child; Child, Preschool; Citalopram; Databases, Factual; Fluoxetine; Fluvoxamine; Humans; Infant; Mental Disorders; Paroxetine; Practice Patterns, Physicians'; Selective Serotonin Reuptake Inhibitors; Sertraline | 2013 |
Comparing effects of citalopram with fluoxetine on sleep quality in patients with major depressive disorder.
Topics: Adolescent; Adult; Citalopram; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Young Adult | 2013 |
NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the gerbil forced swim test.
Topics: Animals; Antidepressive Agents; Aprepitant; Citalopram; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Gerbillinae; HEK293 Cells; Humans; Immobility Response, Tonic; Male; Morpholines; Neurokinin-1 Receptor Antagonists; Piperidines; Prefrontal Cortex; Radioligand Assay; Receptors, Neurokinin-1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2013 |
Fluoxetine and citalopram decrease microglial release of glutamate and D-serine to promote cortical neuronal viability following ischemic insult.
Topics: Animals; Brain Ischemia; Cell Hypoxia; Cell Survival; Cells, Cultured; Cerebral Cortex; Citalopram; Coculture Techniques; Fluoxetine; Glutamic Acid; Interleukin-1beta; Isomerism; Microglia; Neurons; Nitric Oxide; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serine; Tumor Necrosis Factor-alpha | 2013 |
The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent.
Topics: Animals; Antidepressive Agents; Citalopram; Diet; Excitatory Amino Acid Antagonists; Fenclonine; Fluoxetine; Hindlimb Suspension; Male; Mice; Mice, Inbred C57BL; Motor Activity; Piperidines; Receptors, Kainic Acid; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Thiazoles; Tryptophan | 2014 |
Antidepressants share the ability to increase catecholamine output in the bed nucleus of stria terminalis: a possible role in antidepressant therapy?
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Citalopram; Desipramine; Dopamine; Dose-Response Relationship, Drug; Fluoxetine; Imipramine; Male; Morpholines; Norepinephrine; Rats, Sprague-Dawley; Reboxetine; Septal Nuclei; Time Factors | 2014 |
Effects of antidepressant drugs on synaptic protein levels and dendritic outgrowth in hippocampal neuronal cultures.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cell Enlargement; Cells, Cultured; Citalopram; Dendrites; Fluoxetine; Hippocampus; Imipramine; Nerve Tissue Proteins; Neurons; Paroxetine; Rats; Rats, Sprague-Dawley; Sertraline; Thiazepines; Tranylcypromine | 2014 |
Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Benzofurans; Brain; Citalopram; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Space; Fluoxetine; Indoles; Male; Paroxetine; Piperazines; Pyridines; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists; Vilazodone Hydrochloride | 2014 |
The discovery of Yuanzhi-1, a triterpenoid saponin derived from the traditional Chinese medicine, has antidepressant-like activity.
Topics: Animals; Antidepressive Agents; Citalopram; Cocaine; Depression; Disease Models, Animal; Female; Fluoxetine; Male; Medicine, Chinese Traditional; Membrane Transport Proteins; Mice; Mice, Inbred ICR; Motor Activity; Protein Binding; Rats; Rats, Sprague-Dawley; Saponins; Swimming; Tritium | 2014 |
Bacillus Calmette-Guérin vaccine induces a selective serotonin reuptake inhibitor (SSRI)-resistant depression like phenotype in mice.
Topics: Animals; BCG Vaccine; Behavior, Animal; Brain; Citalopram; Depressive Disorder, Treatment-Resistant; Fluoxetine; Interferon-gamma; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Motor Activity; Phenotype; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins | 2014 |
Prophylactic efficacy of fluoxetine, escitalopram, sertraline, paroxetine, and concomitant psychotherapy in major depressive disorder: outcome after long-term follow-up.
Topics: Adult; Citalopram; Cognitive Behavioral Therapy; Cohort Studies; Combined Modality Therapy; Depressive Disorder, Major; Female; Fluoxetine; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Paroxetine; Prospective Studies; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
Perinatal vs genetic programming of serotonin states associated with anxiety.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety Disorders; Brain; Citalopram; Disease Models, Animal; Exploratory Behavior; Female; Fluoxetine; Male; Mice, 129 Strain; Mice, Knockout; Motor Activity; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Synaptic Transmission | 2015 |
Therapeutic Drug Monitoring of Selective Serotonin Reuptake Inhibitors in Elderly Patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Child; Citalopram; Databases, Factual; Drug Monitoring; Drug Utilization; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Norway; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2015 |
Fluoxetine and S-citalopram inhibit M1 activation and promote M2 activation of microglia in vitro.
Topics: Animals; Antidepressive Agents; Cells, Cultured; Citalopram; Cytokines; Fluoxetine; Mice; Microglia; Selective Serotonin Reuptake Inhibitors | 2015 |
Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.
Topics: Adult; Asia, Eastern; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Middle Aged; Pain; Paroxetine; Prospective Studies; Quality of Life; Regression Analysis; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2016 |
Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus.
Topics: Animals; Antidepressive Agents; Benzodiazepines; Bicuculline; Citalopram; Depressive Disorder; Disease Models, Animal; Dorsal Raphe Nucleus; Female; Fluoxetine; GABA-A Receptor Antagonists; GABAergic Neurons; Male; Mice, Inbred C57BL; Neural Inhibition; Olanzapine; Piperazines; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonergic Neurons; Serotonin Antagonists; Sulfonamides; Tissue Culture Techniques | 2015 |
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
Evaluation of the role of NMDA receptor function in antidepressant-like activity. A new study with citalopram and fluoxetine in the forced swim test in mice.
Topics: 2-Amino-5-phosphonovalerate; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Depression; Drug Evaluation, Preclinical; Fluoxetine; Male; Mice; Receptors, N-Methyl-D-Aspartate; Swimming | 2015 |
The side-by-side exploratory test: a simple automated protocol for the evaluation of adult zebrafish behavior simultaneously with social interaction.
Topics: Animals; Bromazepam; Buspirone; Citalopram; Clonazepam; Dose-Response Relationship, Drug; Exploratory Behavior; Fear; Female; Fluoxetine; Male; Pattern Recognition, Automated; Psychological Tests; Psychotropic Drugs; Social Behavior; Software; Stress, Psychological; Vision, Ocular; Zebrafish | 2015 |
Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay.
Topics: Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Citalopram; Estradiol; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Progesterone; Selective Serotonin Reuptake Inhibitors; Sertraline; Testosterone | 2015 |
Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs.
Topics: Analgesics; Antidepressive Agents; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; HEK293 Cells; Humans; Membrane Potentials; Moclobemide; Monoamine Oxidase Inhibitors; NAV1.7 Voltage-Gated Sodium Channel; NAV1.8 Voltage-Gated Sodium Channel; Paroxetine; Patch-Clamp Techniques; Selective Serotonin Reuptake Inhibitors; Sodium Channel Blockers; Time Factors; Transfection | 2015 |
MiR-335 is involved in major depression disorder and antidepressant treatment through targeting GRM4.
Topics: Adolescent; Antidepressive Agents; Case-Control Studies; Child; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; HEK293 Cells; Humans; Male; MicroRNAs; Molecular Targeted Therapy; Neural Stem Cells; Receptors, Metabotropic Glutamate | 2015 |
Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse.
Topics: Animals; Antidepressive Agents; Brain; Cell Proliferation; Cell Survival; Citalopram; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Gene Expression Regulation; Hindlimb Suspension; Hippocampus; Male; Methionine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Serotonin; Serotonin Plasma Membrane Transport Proteins; Synaptosomes | 2016 |
Dosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box Warning.
Topics: Adolescent; Adult; Antidepressive Agents; Child; Child, Preschool; Citalopram; Cohort Studies; Databases, Factual; Depression; Dose-Response Relationship, Drug; Drug Labeling; Drug Prescriptions; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Practice Guidelines as Topic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Suicide, Attempted; United States; United States Food and Drug Administration; Young Adult | 2016 |
Comparison of antidepressant classes and the risk and time course of suicide attempts in adults: propensity matched, retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Comorbidity; Databases, Factual; Depressive Disorder; Female; Fluoxetine; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; United States; Young Adult | 2016 |
Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
Topics: Adolescent; Adult; Aged; Animals; Antidepressive Agents; Cell Survival; Citalopram; Depressive Disorder, Major; Dorsal Raphe Nucleus; Fluoxetine; Genotype; Hippocampus; Humans; Mice; Mice, Knockout; Middle Aged; Neurons; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Translational Research, Biomedical; Young Adult | 2016 |
Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Fluoxetine; Imipramine; Mice; Motor Activity; Piperidines; Receptors, N-Methyl-D-Aspartate; Swimming; Treatment Outcome | 2016 |
Electrospun fibrous thin film microextraction coupled with desorption corona beam ionization-mass spectrometry for rapid analysis of antidepressants in human plasma.
Topics: Animals; Antidepressive Agents; Calibration; Carbon; Carbon Fiber; Citalopram; Fluoxetine; Humans; Hydrophobic and Hydrophilic Interactions; Limit of Detection; Reproducibility of Results; Silicon Dioxide; Solid Phase Microextraction; Spectrometry, Mass, Electrospray Ionization; Time Factors | 2016 |
Differential Associations of Specific Selective Serotonin Reuptake Inhibitors With Resting-State Heart Rate and Heart Rate Variability: Implications for Health and Well-Being.
Topics: Adult; Aged; Brazil; Citalopram; Electrocardiography; Female; Fluoxetine; Heart Rate; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation.
Topics: Adamantane; Administration, Intravenous; Anti-Anxiety Agents; Cannabinoid Receptor Agonists; Citalopram; Female; Fluoxetine; Hallucinations; Hallucinogens; Humans; Indazoles; Indoles; Lysergic Acid Diethylamide; Midazolam; Psychomotor Agitation; Quinolines; Seizures; Tachycardia; Time Factors; Young Adult | 2016 |
Which SSRIs most effectively treat depression in adolescents?
Topics: Adolescent; Adolescent Behavior; Antidepressive Agents; Behavior Therapy; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Multi-biomarker investigation to assess toxicity induced by two antidepressants on Dreissena polymorpha.
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers; Catalase; Citalopram; Dreissena; Fluoxetine; Glutathione Transferase; Lipid Peroxidation; Micronucleus Tests; Oxidative Stress; Protein Carbonylation; Superoxide Dismutase; Water Pollutants, Chemical | 2017 |
Inhibition of the Serotonin Transporter Is Altered by Metabolites of Selective Serotonin and Norepinephrine Reuptake Inhibitors and Represents a Caution to Acute or Chronic Treatment Paradigms.
Topics: Animals; Citalopram; Fluoxetine; Mice; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Synaptosomes | 2017 |
Inhibition of the NMDA and AMPA receptor channels by antidepressants and antipsychotics.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Atomoxetine Hydrochloride; Brain; Chlorpromazine; Citalopram; Desipramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoxetine; Magnesium; Male; Membrane Potentials; N-Methylaspartate; Neurons; Neurotransmitter Agents; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2017 |
Gene expression and proliferation biomarkers for antidepressant treatment resistance.
Topics: Adult; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; Biomarkers; Cell Line; Cell Proliferation; Citalopram; Depressive Disorder, Treatment-Resistant; Female; Fluoxetine; Frizzled Receptors; Glycoproteins; Humans; In Vitro Techniques; Lymphoid Progenitor Cells; Male; Middle Aged; Real-Time Polymerase Chain Reaction; Sulfotransferases; Transcription Factor 7-Like 2 Protein; Transcriptome; Wnt Proteins | 2017 |
Pediatric ingestion of vilazodone compared to other selective serotonin reuptake inhibitor medications.
Topics: Child; Child, Preschool; Citalopram; Coma; Dose-Response Relationship, Drug; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Hospitalization; Humans; Infant; Male; Paroxetine; Poison Control Centers; Retrospective Studies; Seizures; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Vilazodone Hydrochloride | 2017 |
Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Drug Interactions; Fluoxetine; Frontal Lobe; Gene Expression Regulation; Hippocampus; Mianserin; Mirtazapine; Rats; Rats, Wistar; Risperidone; RNA, Messenger; Serotonin Antagonists | 2017 |
Neonatal fluoxetine exposure modulates serotonergic neurotransmission and disturb inhibitory action of serotonin on food intake.
Topics: Age Factors; Animals; Animals, Newborn; Body Weight; Citalopram; Eating; Female; Fluoxetine; Food Deprivation; Gene Expression Regulation; Hypothalamus; Male; Neural Inhibition; Rats; Rats, Wistar; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Synaptic Transmission | 2019 |
Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depressive Disorder; Doxepin; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Paroxetine; Patient Acceptance of Health Care; Reboxetine; Selective Serotonin Reuptake Inhibitors; Stroke; Treatment Outcome | 2017 |
Differential effects of neonatal SSRI treatments on hypoxia-induced behavioral changes in male and female offspring.
Topics: Animals; Animals, Newborn; Behavior, Animal; Citalopram; Disease Models, Animal; Female; Fluoxetine; Hippocampus; Hypoxia; Male; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Serotonin | 2017 |
Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Citalopram; Diabetes Complications; Diuretics; Electrocardiography; Female; Fluoxetine; Furosemide; Heart; Heart Rate; Histamine H1 Antagonists; Humans; Hydroxyzine; Male; Metolazone; Middle Aged; Proton Pump Inhibitors; Renal Insufficiency, Chronic; Venlafaxine Hydrochloride | 2017 |
Mouse strain differences in SSRI sensitivity correlate with serotonin transporter binding and function.
Topics: Animals; Citalopram; Depression; Fluoxetine; Hindlimb Suspension; Male; Mice, Inbred C57BL; Mice, Inbred DBA; Paroxetine; Protein Binding; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Species Specificity; Swimming; Synaptosomes | 2017 |
Prescription Pattern of Antidepressants for Children and Adolescents in Korea Based on Nationwide Data.
Topics: Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Child; Citalopram; Databases, Factual; Depressive Disorder; Drug Prescriptions; Female; Fluoxetine; Humans; Hypnotics and Sedatives; Male; National Health Programs; Republic of Korea | 2017 |
Obsession of pregnancy: Does it exist?
Topics: Attitude to Health; Citalopram; Clomipramine; Clonazepam; Cognitive Behavioral Therapy; Depressive Disorder; Diagnosis, Differential; Female; Fluoxetine; GABA Modulators; Humans; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors | 2017 |
Chronic treatment with caffeine and its withdrawal modify the antidepressant-like activity of selective serotonin reuptake inhibitors in the forced swim and tail suspension tests in mice. Effects on Comt, Slc6a15 and Adora1 gene expression.
Topics: Amino Acid Transport Systems, Neutral; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Cerebral Cortex; Citalopram; Depression; Disease Models, Animal; Drug Administration Schedule; Fluoxetine; Hindlimb Suspension; Male; Mice; Motor Activity; Receptor, Adenosine A1; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Swimming; Time Factors | 2017 |
Differential effects of serotonin reuptake inhibitors fluoxetine and escitalopram on bone markers and microarchitecture in Wistar rats.
Topics: Animals; Antidepressive Agents; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Citalopram; Fluoxetine; Male; Osteogenesis; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin | 2018 |
Fatal intoxication with antidepressants: a case with many culprits.
Topics: Adult; Bipolar Disorder; Cardiomyopathy, Hypertrophic; Citalopram; Fluoxetine; Genotype; Heterozygote; Humans; Male; Pharmacogenomic Variants; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins | 2018 |
Discontinuation and dose adjustment of metoprolol after metoprolol-paroxetine/fluoxetine co-prescription in Dutch elderly.
Topics: Aged; Aged, 80 and over; Citalopram; Cohort Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Prescriptions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Metoprolol; Middle Aged; Mirtazapine; Netherlands; Paroxetine | 2018 |
Looking for bipolarity in antidepressant discontinuation manic states: Update and diagnostic considerations of the phenomenon.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Child; Citalopram; Cyclothymic Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Surveys and Questionnaires; Young Adult | 2018 |
Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
Topics: Altitude Sickness; Animals; Antidepressive Agents; Brain; Citalopram; Dopamine; Female; Fluoxetine; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming | 2018 |
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
Topics: Antidepressive Agents; Basal Ganglia Diseases; Bupropion; Case-Control Studies; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pharmacoepidemiology; Sertraline; United States; Venlafaxine Hydrochloride | 2018 |
Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Benzofurans; Citalopram; Depression; Depressive Disorder, Major; Eukaryotic Initiation Factor-4E; Female; Fluoxetine; Inflammation; Ketamine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-KappaB Inhibitor alpha; Phosphorylation; Protein Biosynthesis; Protein Serine-Threonine Kinases; Serotonin and Noradrenaline Reuptake Inhibitors; Synaptic Transmission; Tumor Necrosis Factor-alpha | 2018 |
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Citalopram; Epithelial Cells; Fluoxetine; Paroxetine; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Sertraline; Swine | 2018 |
Preliminary evidence of an association between increased cortical inhibition and reduced suicidal ideation in adolescents treated for major depression.
Topics: Adolescent; Adolescent Behavior; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Motor Cortex; Neural Inhibition; Suicidal Ideation; Suicide Prevention; Transcranial Magnetic Stimulation | 2019 |
Antidepressant Prescription Patterns in Bipolar Disorder: a Nationwide, Register-based Study in Korea.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Bupropion; Citalopram; Female; Fluoxetine; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Prevalence; Registries; Republic of Korea | 2018 |
Effect of monoamine reuptake inhibition and α
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Citalopram; Duloxetine Hydrochloride; Electroshock; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Prazosin; Reboxetine; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Sudden Unexpected Death in Epilepsy | 2019 |
Effects of monoamine uptake inhibitors on pain-related depression of nesting in mice.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Bupropion; Citalopram; Conditioning, Operant; Dopamine Uptake Inhibitors; Fluoxetine; Ketoprofen; Lactic Acid; Male; Mice; Mice, Inbred ICR; Milnacipran; Nesting Behavior; Pain; Receptors, Opioid, kappa; Self Stimulation | 2019 |
Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
Topics: Adolescent; Citalopram; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Fluoxetine; Humans; Monte Carlo Method; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2019 |
A functional variant in the serotonin receptor 7 gene (HTR7), rs7905446, is associated with good response to SSRIs in bipolar and unipolar depression.
Topics: Adult; Aged; Aged, 80 and over; Animals; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Receptors, Serotonin; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2020 |
Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Topics: Age Factors; Aged; Aged, 80 and over; Cardiac Conduction System Disease; Citalopram; Death, Sudden, Cardiac; Depression; Electrocardiography; Female; Fluoxetine; Fluvoxamine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peroxidase; Registries; Renal Dialysis; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States | 2019 |
Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis.
Topics: Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depression; Depressive Disorder, Major; Fluoxetine; Humans; Longitudinal Studies; Outcome Assessment, Health Care; Paroxetine; Placebos; Psychiatric Status Rating Scales; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2019 |
A UPLC-MS/MS Assay for Simultaneous Determination of Two Antipsychotics and Two Antidepressants in Human Plasma and Its Application in Clinic.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Citalopram; Drug Monitoring; Fluoxetine; Humans; Risperidone; Tandem Mass Spectrometry | 2020 |
Serotonin and serotonin reuptake inhibitors alter placental aromatase.
Topics: Aromatase; Cells, Cultured; Citalopram; Female; Fluoxetine; Humans; Molecular Docking Simulation; Paroxetine; Placenta; Pregnancy; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Trophoblasts; Venlafaxine Hydrochloride | 2019 |
Benefit of small dose antidepressants for functional dyspepsia: Experience from a tertiary center in eastern China.
Topics: Anthracenes; Antidepressive Agents; China; Citalopram; Drug Combinations; Dyspepsia; Female; Fluoxetine; Flupenthixol; Humans; Male; Middle Aged; Mirtazapine; Postprandial Period; Remission Induction; Retrospective Studies; Treatment Outcome | 2019 |
Analysis of tail coiling activity of zebrafish (Danio rerio) embryos allows for the differentiation of neurotoxicants with different modes of action.
Topics: Animals; Cadmium; Citalopram; Dichlorvos; Ecotoxicology; Embryo, Nonmammalian; Embryonic Development; Environmental Indicators; Fluoxetine; Movement; Neurotoxicity Syndromes; Tail; Toxicity Tests; Water Pollutants, Chemical; Zebrafish | 2019 |
Antidepressant treatment strategy with an early onset of action improves the clinical outcome in patients with major depressive disorder and high anxiety: a multicenter and 6-week follow-up study.
Topics: Antidepressive Agents; Anxiety; Citalopram; Depressive Disorder, Major; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Least-Squares Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2020 |
Selective Inhibition of the Serotonin Transporter in the Treatment of Depression: Sertraline, Fluoxetine and Citalopram.
Topics: Citalopram; Depression; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2020 |
Putative role of GPR139 on sleep modulation using pharmacological and genetic rodent models.
Topics: Animals; Citalopram; Dextroamphetamine; Dopamine; Fluoxetine; Male; Mice, Inbred C57BL; Mice, Knockout; Models, Animal; Nerve Tissue Proteins; Norepinephrine; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Serotonin; Sleep | 2020 |
Do environmentally relevant concentrations of fluoxetine and citalopram impair stress-related behavior in zebrafish (Danio rerio) embryos?
Topics: Animals; Behavior, Animal; Bioaccumulation; Citalopram; Embryo, Nonmammalian; Environmental Exposure; Fluoxetine; Oxidative Stress; Selective Serotonin Reuptake Inhibitors; Swimming; Water Pollutants, Chemical; Zebrafish | 2020 |
Urinary selective serotonin reuptake inhibitors across critical windows of pregnancy establishment: a prospective cohort study of fecundability and pregnancy loss.
Topics: Abortion, Spontaneous; Adult; Citalopram; Female; Fertility; Fluoxetine; Humans; Live Birth; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; United States; Young Adult | 2020 |
Can the Risk of Severe Depression-Related Outcomes Be Reduced by Tailoring the Antidepressant Therapy to Patient Characteristics?
Topics: Adult; Aged; Antidepressive Agents; Citalopram; Cohort Studies; Databases, Factual; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Precision Medicine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Survival Analysis; Treatment Outcome; United Kingdom | 2021 |
Low SSRI dosing in clinical practice-a register-based longitudinal study.
Topics: Child; Citalopram; Fluoxetine; Humans; Longitudinal Studies; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2021 |
Serotonergic inhibition of responding for conditioned but not primary reinforcers.
Topics: Animals; Citalopram; Conditioning, Classical; Cues; Dorsal Raphe Nucleus; Duloxetine Hydrochloride; Female; Fluoxetine; Gene Knockout Techniques; Male; Mice; Mice, Inbred C57BL; Motivation; Neurons; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin; Tryptophan Hydroxylase | 2021 |
Sensitive determination of Fluoxetine and Citalopram antidepressants in urine and wastewater samples by liquid chromatography coupled with photodiode array detector.
Topics: Antidepressive Agents; Chromatography, Liquid; Citalopram; Fluoxetine; Humans; Limit of Detection; Solid Phase Extraction; Solvents; Spectrophotometry, Ultraviolet; Wastewater; Water Pollutants, Chemical | 2021 |
Early Developmental Exposure to Fluoxetine and Citalopram Results in Different Neurodevelopmental Outcomes.
Topics: Anxiety; Citalopram; Female; Fluoxetine; Humans; Patch-Clamp Techniques; Pregnancy; Selective Serotonin Reuptake Inhibitors | 2021 |
Antidepressants Differentially Regulate Intracellular Signaling from α1-Adrenergic Receptor Subtypes In Vitro.
Topics: Animals; Antidepressive Agents; Citalopram; Depression; Desipramine; Fluoxetine; Gene Expression Regulation; Humans; Imipramine; Mianserin; Mice; PC12 Cells; Rats; Reboxetine; Receptors, Adrenergic, alpha-1; Signal Transduction | 2021 |
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study.
Topics: Antidepressive Agents; Bupropion; Citalopram; Duloxetine Hydrochloride; Escitalopram; Female; Fluoxetine; Humans; Infant, Newborn; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2021 |
Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.
Topics: Adult; Aged; Antidepressive Agents; Citalopram; COVID-19; Cytokines; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Prescription Drugs; Retrospective Studies; Risk; SARS-CoV-2; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; United States | 2021 |
Occurrence and fate of chiral and achiral drugs in estuarine water - a case study of the Clyde Estuary, Scotland.
Topics: Animals; Citalopram; Estuaries; Fishes; Fluoxetine; Water; Water Pollutants, Chemical | 2022 |
Investigation of the potential association between the use of fluoxetine and occurrence of acute pancreatitis: a Danish register-based cohort study.
Topics: Acute Disease; Citalopram; Cohort Studies; Denmark; Fluoxetine; Humans; Pancreatitis; Selective Serotonin Reuptake Inhibitors | 2022 |
Antidepressants Are Poor Inhibitors of Heat-Evoked Ion Currents Mediated by TRPM2.
Topics: Adenosine Diphosphate Ribose; Amitriptyline; Animals; Antidepressive Agents; Citalopram; Duloxetine Hydrochloride; Fluoxetine; HEK293 Cells; Hot Temperature; Humans; Ketamine; Lidocaine; Mice; Paroxetine; Pregabalin; Sertraline; TRPM Cation Channels | 2022 |
SSRI antidepressants differentially modulate serotonin reuptake and release in Drosophila.
Topics: Animals; Antidepressive Agents; Citalopram; Drosophila; Drosophila melanogaster; Fluoxetine; Mammals; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin | 2022 |
The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
Topics: Case-Control Studies; Citalopram; Cohort Studies; Death, Sudden, Cardiac; Dialysis Solutions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Potassium; Renal Dialysis; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2022 |
Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study.
Topics: Body Weight; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Fluoxetine; Humans; Paroxetine; Phenotype; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2022 |
Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths.
Topics: Adolescent; Antipsychotic Agents; Citalopram; Diabetes Mellitus, Type 2; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2022 |
Topics: Antidepressive Agents; Antiviral Agents; Citalopram; COVID-19; Fluoxetine; Humans; Molecular Docking Simulation; Papain; Peptide Hydrolases; Protease Inhibitors; SARS-CoV-2; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2023 |
Using filled prescription sequences to rank antidepressants: A nationwide replication study.
Topics: Antidepressive Agents; Citalopram; Fluoxetine; Humans; Paroxetine; Venlafaxine Hydrochloride | 2023 |
Selective Serotonin Reuptake Inhibitors within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane.
Topics: Animals; Citalopram; Depressive Disorder, Major; Endoplasmic Reticulum; Escitalopram; Fluoxetine; Humans; Mammals; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2023 |
FKBP5 blockade may provide a new horizon for the treatment of stress-associated disorders: An in-silico study.
Topics: Citalopram; Clomipramine; Duloxetine Hydrochloride; Fluoxetine; Humans; Sertraline; United States | 2023 |
Effects of three serotonin reuptake inhibitors on sign-tracking in male Sprague-Dawley rats.
Topics: Animals; Antidepressive Agents; Citalopram; Fluoxetine; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2023 |